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 Abbreviations 
 
11-β-HSD-2  11-β-hydroxysteroid dehydrogenase type 2 
AIP   aldosterone-induced proteins 
ASDN   aldosterone-sensitive distal nephron 
Atf3   activating transcription factor 3 
bp   base pair 
BSA   bovine serum albumin 
cAMP   cyclic AMP 
(C)CD   (cortical) collecting duct 
CFTR   cystic fibrosis transmembrane conductance regulator 
CNS   central nervous system 
CNT   connecting tubule 
Crem   cAMP responsive element modulator 
cRNA   copy RNA 
dNTP   deoxynucleotide-triphosphate 
DCT   distal convoluted tubule 
DTT   dithiothreitol 
DUB   de-ubiquitinating enzyme 
E1   ubiquitin-activating enzyme 
E2   ubiquitin-conjugating enzyme 
E3   ubiquitin-protein ligase 
EDTA   ethylenediaminetetraacetic acid 
ENaC   epithelial Na+ channel 
ERK   extracellular signal-regulated kinase 
EST   expressed sequence tag 
GFR   glomerular filtration rate 
GR   glucocorticoid receptor 
h   hour(s) 
HECT   homologous to E6-AP carboxyterminal 
HEPES  4-(2-hydroxyethyl)-1-piperazineethanesulphonic acid 
IVT   in vitro translation/translated 
kb   kilobase 
kDa   kilo Dalton 
MCD   medullary collecting duct 
min   minute(s) 
MOPS  3-(N-morpholino) propanesulphonic acid 
MAPK   mitogen-activated protein kinase 
MR   mineralocorticoid receptor 
Nav   voltage-gated Na+ channel 
Nedd   neural precursor cell expressed, developmentally down- 
regulated 
NHE   Na+/H+ exchanger 
NMDG  N-methyl-D-glucamine 
PAGE   polyacrylamide gel electrophoresis 
PBS   phosphate-buffered saline 
PCR   polymerase chain reaction 
PHA1   pseudohypoaldosteronism type 1 
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PI3-K   phosphoinositide 3-kinase 
PKA   protein kinase A 
PKC   protein kinase C 
PT   proximal tubule 
PVDF   polyvinylidine difluoride 
PY   motif PPxY or LPxY sequence 
RAAS   renin-angiotensin aldosterone system  
RT   room temperature 
RT-PCR  reverse transcriptase-PCR 
SDS   sodium dodecyl sulphate 
SE   standard error 
SEM   standard error of mean 
Sgk   serum and glucocorticoid-regulated kinase 
Slc   solute carrier family 
TAE   Tris-Ac-EDTA 
TAL   thick ascending limb 
TEMED  N, N, N’, N’-tetramethylethylene diamine 
TGFβ   transforming growth factor-β 
Ub   ubiquitin 
UBP   ubiquitin-specific processing enzyme 
UCH   ubiquitin carboxyl terminal hydrolase 
Usp   ubiquitin-specific proteases 
WW1, 2, 3 or 4 WW domain 1, 2, 3 or 4 
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 Abstract 
 
The epithelial Na+ channel (ENaC), located in the apical membrane of renal 
aldosterone-responsive epithelia, plays an essential role in controlling the Na+ 
balance of extracellular fluids and hence blood pressure. Moreover, ENaC is the 
only Na+ transport protein for which genetic evidence exists for its involvement in 
the genesis of both hypertension (Liddle's syndrome) and hypotension 
(pseudohypoaldosteronism type 1) revealing that the regulation of ENaC is of 
fundamental importance. 
The final adjustment of NaCl reabsorption under the control of the 
mineralocorticoid hormone aldosterone takes place in the principal cells of the 
collecting duct in the distal nephron of the kidney. The stimulatory action of 
aldosterone on Na+ reabsorption and K+ secretion can be arbitrarily divided in an 
early regulatory phase, which can be observed within 30 min after initiating a 
hormonal treatment, and a late anabolic phase. The early actions are thought to 
be mediated mostly by the induction/repression of proteins belonging to the 
regulatory pathways that control the function of pre-existing transport effectors 
such as ENaC (apical entry of Na+), the Na+,K+-ATPase (basolateral extrusion of 
Na+) and K+-channels. 
For many years the only regulatory proteins that had been identified and 
experimentally shown to have an impact on ENaC function were K-Ras2, in 
amphibian cells, and the serum and glucocorticoid-regulated kinase Sgk1 that is 
also regulated in mammalian kidney. 
The main focus of my doctoral thesis was to identify in the aldosterone sensitive 
distal nephron in vivo, new early aldosterone-induces gene products in particular 
encoding regulatory proteins other than Sgk1. 
An important mechanism by which SGK1 stimulates ENaC cell-surface expression 
and function is by phosphorylating the ubiquitin-protein ligase Nedd4-2 and 
thereby interfering with the ubiquitylation of ENaC and controlling its cell-surface 
expression or endosomal/lysosomal degradation. Nedd4-2 binds to the PY motif in 
the COOH-termini of ENaC subunits and ubiquitylates ENaC on lysine residues 
situated in the NH2 termini, thereby inducing channel downregulation at the 
plasma membrane. The short signaling cascade leading from Sgk1 induction via 
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inhibition of Nedd4-2 to the activation of ENaC represents so far the first direct link 
between the aldosterone-regulated transcriptional activity of the mineralocorticoid 
receptor and the activation of ENaC that has been demonstrated. 
In this present study we established a new in vivo strategy involving Affymetrix® 
GeneChip® technique, with which we identified new early aldosterone-regulated 
mRNAs in microselected mouse distal nephron of control and aldosterone treated 
mice. From the 22 mRNAs that displayed a ≥ 2-fold change, 13 were 
downregulated. The later ones included a putative G0/G1 switch gene, a 
polyspecific organic anion transporter (Slc22a8) and the colonic H+,K+-ATPase. 
The 9 upregulated mRNAs included besides Sgk1 the ubiquitin protease Usp2-45 
components of the TGFβ pathway and members of the CREB family of 
transcription factors (Grem2, Atf3 and Crem). 
We showed, using expression in Hek293 cells, Xenopus oocytes and mpkCCDc14 
cells, that Usp2-45 deubiquitylates ENaC and stimulates ENaC-mediated sodium 
transport, an effect that is not additive to that of Sgk1. Furthermore, we show both 
that the disruption of ENaC PY motifs and the disruption of ENaC lysine residues 
potentially targeted by Usp2-45 prevent the action of Usp2-45 on ENaC function. 
These results also strongly support the hypothesis that Usp2-45 acts on ubiquitin 
moieties ligated onto ENaC by the ubiquitin ligase Nedd4-2. The Affymetrix screen 
presented in this work revealed that approximately 26 different Usp’s are 
expressed in the aldosterone target cells of the mouse kidney tubule, but only the 
RNA of Usp2-45 was significant differentially regulated more than 2-fold. 
In summary, our list of early aldosterone-regulated gene products contains two 
induced elements that interfere with the ubiquitylation of ENaC. Besides Sgk1 we 
identified Usp2-45 that we show to deubiquitylate ENaC in expression systems 
and thus represent a first example of a hormonally controlled deubiquitylating 
enzyme acting on a channel. 
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 Zusammenfasssung 
 
In der Niere ist der epitheliale Na+-Kanal (ENaC) in der apikalen Membran der 
Aldosteron-sensitiven Epithelzellen lokalisiert. Dieser Kanal spielt eine wesentliche 
Rolle für die Kontrolle der Na+-Homöostase und des Extrazellulärvolumens und ist 
folglich an der langfristigen Regulation des Blutdruckes maßgeblich beteiligt. 
Darüber hinaus ist bekannt, dass Mutationen von ENaC ursächlich für die 
Entstehung der arteriellen Hypertonie (Liddle-Syndrom) als auch der Hypotonie 
(Pseudohypoaldosteronismus Typ 1) beim Menschen sein können. Diese 
Zusammenhänge veranschaulichen die zentrale Bedeutung der exakten 
Regulation von ENaC unter physiologischen und pathophysiologischen 
Bedingungen. 
Die bedarfsgerechte Feineinstellung der NaCl-Reabsorption in der Niere steht 
unter der Kontrolle des Mineralokortikoidhormons Aldosteron und wird durch die 
Hauptzellen des Sammelrohres im distalen Nephron bewerkstelligt. Der 
stimulierende Effekt des Aldosterons auf die Na+-Reabsorption und K+-
Ausscheidung kann in eine frühe regulatorische Phase, die innerhalb von 30 
Minuten nach Aldosterongabe beobachtet werden kann, und in eine späte 
trophische Phase eingeteilt werden. Es wird vermutet, dass die frühen Wirkungen 
von Aldosteron hauptsächlich durch die Induktion bzw. Repression regulatorischer 
Proteine vermittelt werden. Diese Regulatoren beeinflussen in komplexer Weise 
bereits vorhandene Transportproteine, wie z.B. luminale ENaC- und K+-Kanäle 
und basolaterale Na+,K+-ATPasen. 
Für viele Jahre waren die einzigen Aldosteron-induzierten regulatorischen 
Proteine, die man identifiziert hatte und für die experimentell eine Wirkung auf die 
ENaC-Funktion nachgewiesen werden konnte, K-Ras2 und die Serum- und 
Glukokorticoid-regulierte Kinase Sgk1. 
Ein wichtiger Mechanismus, durch welchen Sgk1 die Zelloberflächen-Expression 
und Funktion von ENaC stimuliert, besteht in der Sgk1-abhängigen 
Phosphorylierung der Ubiquitin-Ligase Nedd4-2. In nicht-phosphoryliertem 
Zustand bindet Nedd4-2 an ein sogenanntes PY Motiv im COOH-Terminus der 
ENaC Untereinheiten und ubiquitinyliert ENaC an Lysin-Resten, die sich im NH2-
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Terminus befinden. Die Ubiquitinylierung von ENaC leitet dann dessen Entfernung 
aus der Plasmamembran und die endosomale/lysosomale Degradation ein. Die 
kurze Signalkaskade, die von der gesteigerten Genexpression der Sgk1 über die 
Hemmung von Nedd4-2 zu einer Vermehrung aktiver ENaC-Kanäle in der 
Membran führt, stellte bis vor kurzem das wichtigste bekannte Bindeglied 
zwischen der transkriptionellen Aktivität des Mineralokortikoidrezeptors und der 
Aldosteron-induzierten Erhöhung der ENaC-Funktion dar. 
 
Das Hauptaugenmerk meiner Doktorarbeit galt der Identifizierung neuer, 
unbekannter Aldosteron-induzierter Genprodukte, die wie Sgk1 im Aldosteron-
sensitiven distalen Nephron unter in vivo Bedingungen den Salztransport 
maßgeblich regulieren. 
 
Wir haben unter Zuhilfenahme der Affymetrix® GeneChip® Technologie eine in 
vivo Strategie etabliert, mit der neue, unbekannte und in einer frühen Phase 
Aldosteron-regulierte mRNAs identifiziert werden können. Als Ausgangsmaterial 
dienten uns mikro-selektierte, distale Nephronsegmente von unbehandelten und 
Aldosteron-behandelten Mäusen. Von den 22 mRNAs, die eine mehr als 2-fache 
Veränderung der Genexpression zeigten, waren 13 herunterreguliert: z.B. das 
mutmaßliche Switcher-Gen G0/G1, der polyspezifische organische Anionen 
Transporter (Slc22a8) oder die Kolon-Typ H+,K+-ATPase. Zu den neun 
hochregulierten mRNAs gehörten nebst Sgk1 die Ubiquitin-Protease Usp2-45, 
Bestandteile des TGFβ-Pathways und verschiedene Transkriptionsfaktoren 
(Grem2, Atf3 und Crem), die der CREB-Familie zugeordnet werden können. 
Interessanterweise wurde von den 26 unterschiedlichen Ubiquitin-Proteasen, die 
in den distalen Nephronsegmenten der Maus detektierbar waren, einzig und allein 
Usp2-45 nach Aldosterongabe mehr als 2-fach vermehrt exprimiert. Wir haben 
daher funktionelle Experimente angestellt, um eine mögliche Wechselwirkung von 
Usp2-45 und ENaC aufzudecken. 
Nach Proteinexpression in Hek293-Zellen, in Xenopus laevis Oozyten und in 
mpkCCDc14-Zellen beobachteten wir, dass ENaC Usp2-45-abhängig 
deubiquitinyliert wurde, was mit einer Stimulation des ENaC-getragenen 
Natriumtransports einherging. Wie zu erwarten, war die Wirkung von Usp2-45 auf 
ENaC nicht additiv zu der Wirkung von Sgk1, da schlussendlich beide Wege zu 
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einer Verminderung der Ubiquitinylierung von ENaC führen. Die Zerstörung des 
für die Ubiquitinylierung wichtigen PY-Motivs und des relevanten Lysin-Restes von 
ENaC führte zu einer Aufhebung der Wirkung von Usp2-45 auf die ENaC-
Funktion. Diese Resultate untermauern die Hypothese, dass Usp2-45 auf die 
Ubiquitin-Reste wirkt, die durch die Ubiquitin-Ligase Nedd4-2 an ENaC gebunden 
werden. 
 
Zusammenfassend kann man sagen, dass unsere Liste der „frühen“ Aldosteron-
regulierten Genprodukte zwei Kandidaten enthält, die mit der Ubiquitinylierung von 
ENaC interferieren: Sgk1 führt zu einer verminderten Ubiquitinylierung durch 
Hemmung von Nedd4-2. Die im Rahmen der Arbeit erstmals als Aldosteron-
reguliertes Gen identifizierte Ubiquitin-Protease Usp2-45 deubiquitinyliert ENaC 
und verhindert auf diesem Weg die Degradation von ENaC. Usp2-45 stellt damit 
das erste Beispiel eines hormonell gesteuerten, deubiquitinylierenden Enzymes 
dar, das auf einen Ionenkanal wirkt. 
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“Salt is born of the purest parents, the sun and the sea.” 
Pythagoras 
 
 
 
 
 
 Introduction 
 
For freshwater animals the salt concentration in the body fluids is higher 
(hyperosmotic) than in the aqueous surroundings. This may result in the excessive 
entry of water into their bodies following the osmotic gradient. To counteract this, 
freshwater animals produce dilute urine and retain salts by active transport across 
the epithelia into the interstitial space. In addition, freshwater animals have 
evolved the remarkable ability to take up salts from their dilute environment. In 
lower vertebrates, such as amphibians, the organs involved in this process are the 
skin and the bladder while in fish the gills serve as the major osmolarity regulators. 
Terrestrial animals have also evolved systems to conserve salt and water: reptiles 
and birds have salt glands while in mammals the kidneys serve this purpose. 
In contrast, for seawater animals, the body fluids are isotonic (marine 
invertebrates) or hypotonic (fish) in respect to the surrounding environment. 
Therefore, seawater fish excrete salt to regulate their fluid osmolarity. 
From an evolutionary point of view the development of the kidney played a 
major role in the migration of vertebrates from the sea to the land [1]. 
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1. General Aspects of Kidney Anatomy and Physiology 
 
Mammalian kidneys are paired, bean-shaped structures, one located on each 
side against the dorsal inner surface of the lower back, outside the peritoneum in a 
mass of fatty tissue (small figure in Figure 1.). The outer functional layer, the 
cortex, is covered by a tough capsule of connective tissue. The inner functional 
layer, the medulla, sends papillae projecting into the renal pelvis that give rise to 
the ureters which later empty into the urinary bladder (Figure 1.). 
 
 
Figure 1. Schematic representation of a longitudinal section through the kidney. 
Adapted from www.adam.about.com. 
 
The kidneys serve three essential functions. They work as filters, removing 
metabolic by-products and toxins (xenobiotics) from the blood and excreting them 
in the urine. They also play a key homeostatic role by regulating the body’s fluid 
status (blood volume and blood pressure), electrolyte, amino acid and acid-base 
balance. And finally, the kidneys produce hormones involved in erythrogenesis, 
calcium metabolism and regulation of blood flow and blood pressure. To fulfill 
these functions the kidneys are very well supplied with blood, receiving 20-25% of 
the total cardiac output per minute at rest corresponding thus to the total blood 
volume every 4-5 minutes. 
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1.1. Anatomy and Functional Principles of the Nephron 
Each day approximately 180 L of fluid are filtered by the human kidneys with  
99 % reabsorbed such that only 1.5 to 2 liters of urine are ultimately excreted. This 
remarkable feature, as well as the reabsorption of water and other valuable 
substances is carried out by several hundred (in lower vertebrates) to many 
thousand (in small mammals), and a million or more nephrons (in humans and 
other large species). The functional unit of the mammalian kidney is the nephron, 
an intricate epithelial tube which is closed at its beginning and open at its distal 
end. Each kidney contains around one million nephrons (in humans), which empty 
into the collecting ducts. The collecting ducts combine to form papillary ducts, 
which eventually empty into the renal pelvis. At the closed end, the nephron is 
expanded to form a cup-shaped Bowman’s capsule (Figure 2.B). The lumen of the 
capsule is continuous with the narrow lumen that extends through the renal tubule. 
A tuft of capillaries forms the renal glomerulus inside Bowman’s capsule. Therein, 
two layers of cells are responsible for filtering from the blood a wide range of high 
molecular compounds including proteins as small as 1-4 nm. The blood passes 
through the single-cell layer of the capillary walls, through a basement membrane, 
and finally enters the Bowman’s capsule through a single-cell layer of epithelium. 
The resulting ultrafiltrate or “primary urine” contains approximately the same 
concentration of electrolytes, sugars, amino acids etc. as is found in the plasma. 
From the Bowman’s capsule the filtrate enters the renal tubule where the 
selective reabsorption of water, inorganic ions and other molecules from the 
glomerular filtrate occurs. 
In terms of morphology, there exist two subtypes of nephrons; the cortical and 
the juxtamedullary nephrons (Figure 2.B). Cortical nephrons have their glomeruli in 
the outer cortex located near the kidney surface and they possess relatively short 
loops of Henle that extend only a short distance into the outer zones of the 
medulla. The juxtamedullary nephrons, in contrast, have their glomeruli in the 
inner part of the cortex located deeper than cortical nephrons and their long loops 
of Henle plunge very deep into the inner zone of the medulla. The wall of the renal 
tubule is one cell layer thick. This epithelium separates the lumen, which contains 
the ultrafiltrate, from the interstitial fluid. In the early portions of the nephron 
epithelial cells are morphologically specialized for a high rate of solute transport, 
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bearing a dense pile of microvilli on their luminal, or apical, surfaces and deep 
infoldings at their baso-lateral membrane. 
Nephrons can be structurally and functionally divided into three main regions or 
segments (Figure 2.B) having distinct roles regarding the reabsorption of ions, 
glucose, amino acids and water. 
 
 
Figure 2. Panel A, anatomical scheme of the kidney: 1. renal artery, 2. renal pelvis, 3. ureter. 4. 
calyx, 5. medulla, 6. cortex; Panel B: schematic representation of superficial and deep nephrons. 1. 
glomerulus, 2. proximal tubule (PROX) 3. proximal straight tubule 4. descending thin limb of the 
loop of Henle (LOH). 5. ascending thin limb of the loop of Henle. 6. thick ascending limb of the loop 
of Henle, 7. macula densa; 8. distal convoluted tubule (DCT); 9. connecting tubule (CT); 10 cortical 
collecting duct (CCD); 11. outer medullary collecting duct; 12 inner medullary collecting duct. 
Adapted from www.umm.edu/transplant/kidney/ and Kriz and Kaissling, 1992. 
 
The segments of the nephron are the proximal nephron (Bowman’s capsule 
and proximal tubule), the loop of Henle (with a descending limb and an ascending 
limb) and the distal nephron (after the ascending limb of the loop of Henle merges 
into the distal tubule). Distal tubules from many nephrons merge into one unique 
collecting duct. 
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1.2. The Segments of the Nephron Tubule 
Filtration of the blood requires a high blood pressure, therefore the blood is led 
directly from arteries via the vasa afferentia into the glomeruli (Figure 2.A and B). 
Plasma is filtered at the level of the glomerulus and as it flows along the nephron 
its composition changes dramatically. While much of the water, electrolytes, 
peptides, amino acids and sugars are reabsorbed by the specialized tubular 
epithelia, other filtrate components such as urea, xenobiotics, organic acids and 
bases and some NaCl, KCl, remain in tubular fluid and end up in the urine (Figure 
3.). As the filtrate flows through the tubule, most filtered Na+ and water are also 
reabsorbed by epithelium of the lining. Under normal conditions, less than 1% of 
the filtered sodium load is excreted. 
 
Figure 3. Na+ reabsorption along 
the mammalian nephron. All Na+ 
transporting cells in the nephron 
express the Na+,K+-ATPase at the 
basolateral membrane (not shown 
at this scheme for clarity). The most 
quantitatively important Na+ entry 
pathways are shown here (NHE3-
sodium/proton exchanger in the 
proximal tubule (PROX), 
furosemide-sensitive Na+,K+,2Cl- 
cotransporter in the loop of Henle 
(LOH), thiazide-sensitive NaCl 
cotransporter in the distal 
convoluted tubule (DCT) and 
amiloride-sensitive epithelial 
soidium channel ENaC in the 
connecting tubule (CNT) and 
cortical and medullary collecting 
ducts (CD). 
Adapted from www.kidneyatlas.org. 
 
 
Figure 3. shows an overview of the morphological segments of the nephron 
tubule. The following description of the morphological and physiological aspects 
includes sodium reabsorption from the tubular fluid into the blood. 
 
1.2.1. The Glomerulus 
The initial part of a nephron, the glomerulus, is formed by a capillary network of 
vessels and is responsible for the filtration of plasma. This structure is 
approximately 0.2 mm in diameter and acts as a coarse filter, allowing all but 
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cellular elements, i.e. blood cells, and plasma large molecular weight proteins to 
pass into the glomerular filtrate. Glomeruli are located in the kidney cortex (Figure 
2.A). 
 
1.2.2. The Proximal tubule (PT) 
The proximal tubule is the initial and phylogenetically the oldest region of the 
tubule system. Anatomically, the PT, which begins immediately following the 
glomerulus, is divided into the proximal convoluted and the proximal straight 
tubule. However, based on ultrastructure, the proximal tubule can alternatively be 
subdivided into three segments: S1, S2 and S3. The S1 segment starts at the 
glomerulus and includes the first portion of the proximal convoluted tubule. The S2 
segment starts within the second half of the proximal convoluted tubule and 
continues into the first half of the proximal straight tubule. Finally, the S3 segment 
includes the distal half of the proximal straight tubule that extends into the medulla. 
Both the apical (luminal) and the basolateral (peritubular) membranes of 
proximal-tubule cells are extensively amplified. The apical membrane contains 
numerous infoldings, called microvilli, forming a well-developed brush border 
system. This enlargement of the apical membrane surface area correlates with the 
main function of this nephron segment, namely, the reabsorption of the bulk of the 
filtered fluid back into the circulation. In the proximal tubule, two thirds of the whole 
fluid is reabsorbed, along with 60-70 % of the filtered sodium, chloride, potassium, 
bicarbonate and phosphate. Further, important nutrients like glucose and amino 
acids are almost entirely reabsorbed. The basolateral membranes of adjacent 
proximal-tubule cells form numerous interdigitations, bringing the abundant supply 
of mitochondria in close contact with the plasma membrane. These organelles 
supply ATP to power the Na+,K+-ATPase pumps which transport Na+ out of and K+ 
into the cell. The interdigitations of the lateral membranes also form an extensive 
extracellular compartment bounded by the tight junctions at one end, and by the 
basement membrane of the epithelium at the other end. Proximal-tubule cells 
contain lysosomes, endocytic vacuoles and a well-developed system of 
endoplasmic reticulum. Proximal-tubule cells are also characterized by a 
prominent Golgi apparatus, which is important for synthesizing many membrane 
components, for sorting them and for targeting them to specific surface sites. 
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Figure 4. Cell of the proximal tubule 
showing the main net entry 
and exit pathways for the indicated ions 
and glucose leading to reabsorption. 
Stimulatory and inhibitory hormones or 
mechanisms regulating these 
reabsorption mechanisms are listed on 
the right side. 
Adapted from www.kidneyatlas.org. 
 
 
 
 
 
 
 
 
From the S1 to the S3 segments, cell complexity progressively decreases, 
correlating with a gradual decline in reabsorptive rates along the tubule, thus, the 
cells exhibit a progressively less developed brush border system, diminished 
complexity of lateral cell interdigitations, a reduced basolateral cell membrane 
area and a decrease in the number of mitochondria. 
Most of the luminal sodium entry (>80 %; Figure 3.) is directly coupled to active 
proton extrusion via the Na+/H+ exchanger NHE-3 [2] and possibly NHE-2 [3] and 
secondarily to bicarbonate or chloride reabsorption. Na+ is extruded across the 
basolateral membrane via the HCO3-/Na+ cotransporter as well as the Na+,K+-
ATPase (Figure 4.). Luminal and basolateral membranes are freely permeable to 
water due to the expression of the water channel aquaporin-1 (AQP-1) [4]. Further, 
the existence of leaky tight junctions permits limited paracellular diffusion of water 
and salt ions from the lumen to the interstitial space. In the PT, the osmolarity of 
the fluid is not altered and therefore remains isotonic. 
 
1.2.3. The Loop of Henle 
The loop of Henle has a crucial role in concentrating the urine. The function of 
the loop of Henle is to produce an increasing osmotic gradient from the cortex to 
the tip of the renal papilla by the counter-current multiplier mechanism. It 
comprises two functionally asymmetric parts, the descending thin and the 
ascending thin and thick limbs (TALs). In the descending thin limb the tubular fluid 
undergoes an increase in osmolarity, since the water permeability of the 
2-
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membrane allows the diffusion of water to the (highly osmolar) blood site. In 
contrast, the entire ascending limb (thin and thick regions) is water impermeable 
and urinary sodium is reabsorbed actively in the thick ascending limb (TAL;   
Figure 3.). 
 
Figure 5. Main sodium and potassium 
transport mechanism in the thick 
ascending limb (TAL) of the loop of Henle 
involved in sodium reabsorption. The 
stimulatory and inhibitory hormones acting 
on this tubular segment and the 
mechanisms regulating the reabsorption 
mechanisms are listed on the right side. 
Adapted from www.kidneyatlas.org. 
 
 
 
 
 
Critically the apical cotransport of Na+, K+ and Cl- into the cells occurs in the 
absence of water permeability leading to the production of a hypotonic urinary 
fluid. 
Regarding the Na+ reabsorption (Figure 3.; ~ 25% of Na+ load), basolaterally 
located Na+,K+-ATPase pumps generate a sodium gradient which is to a large 
extent, dissipated by the apical electroneutral Na+-K+-2Cl- cotransporter [5]. 
The TAL leads back to the glomerulus forming tight contact with the 
juxtaglomerular apparatus, allowing feedback regulation from the distal nephron to 
the glomerulus. The loop of Henle is only present in birds and mammals. 
Vertebrates which lack the loop of Henle are incapable of producing hyperosmolar 
urine. 
 
1.2.4. The Juxtaglomerular Apparatus 
This is a specialization of the glomerular afferent arteriole and the distal 
convoluted tubule in each nephron, which controls glomerular filtration rate (GFR) 
at the level of the individual nephron. It is involved in the regulation of systemic 
blood pressure via the renin-angiotensin-aldosterone mechanism. The 
juxtaglomerular apparatus has three components: macula densa, juxtaglomerular 
cells and extraglomerular mesangial cells. 
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The Macula densa is composed of closely packed tubular epithelial cells found 
at the end of the TAL. The Juxtaglomerular cells are specialized smooth muscle 
cells of the wall of the afferent arteriole forming a cluster around it, just before it 
enters the glomerulus. Finally, the extraglomerular mesangial cells are flat and 
elongated cells embedded in a network of mesangial matrix. Their role in the 
juxtaglomerular apparatus is unclear. 
It is believed that the cells of the macula densa (Figure 3.) respond to NaCl 
concentration within the distal tubule, and in turn regulate both the diameter of the 
afferent arteriole and the secretion of renin by the juxtaglomerular cells. Renin is a 
participant in the renin-angiotensin-aldosterone system, its physiological role in the 
regulation of glomerular filtration, renal tubular reabsorption of Na+ and water will 
be discussed later on. 
 
1.2.5. The Distal Convoluted Tubule (DCT) 
The distal convoluted tubules are located in the cortex, intertwined with the 
proximal convoluted tubules which are longer and then occupy more space. The 
distal tubules can be differentiated from the proximal tubules by the lack of a brush 
border membrane and their lumen is larger and more clearly defined. 
 
 
Figure 6. Mechanisms of sodium chloride 
reabsorption in the distal tubule. The distal 
tubule has predominantly a Na+/Cl- 
cotransporter, which is inhibited by thiazide 
diuretics. In the connecting tubule (CNT), 
sodium channels and a sodium-hydrogen 
exchange mechanism also are present. 
Amiloride inhibits sodium channel activity. 
Again the sodium-potassium ATPase (Na+-K+ 
ATPase) on the basolateral membrane 
provides most of the driving force for sodium 
reabsorption. 
Adapted from www.kidneyatlas.org. 
 
 
 
 
In the distal convoluted tubule, 5 - 7 % of filtered sodium is reabsorbed via a 
variety of sodium transport mechanisms. In the more proximal segments (DCT1) 
Na+ reabsorbtion is achieved by the apical localized thiazide-sensitive Na+-Cl- 
cotransporter (NCC: also termed as TSC), whereas in the more distal (DCT2) 
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segments, the Na+-Cl- cotransporter together with the amiloride-sensitive epithelial 
sodium channel (ENaC) [6] form the apical Na+ transport pathway. This second 
portion of the distal convoluted tubule (DCT2) along with the connecting tuble 
(CNT) and the collecting duct (CD) belong to the Aldosterone Sensitive Distal 
Nephron (ASDN). 
Dietary Na+ restriction, which is a potent stimulus of aldosterone secretion, has 
been demonstrated to increase thiazide-sensitive Na+ transport in DCT [7]. 
 
1.2.6. The Connecting Tubule (CNT) and Collecting Duct (CD) 
The connecting tubules join the distal convoluted tubule to the collecting duct. 
Tubuli of several nephrons run into the collecting duct (CD) channel system. The 
water permeability of the cells of the connecting tubules and of the collecting ducts 
is controlled by the antidiuretic hormone (ADH). The final adjustment (“fine tuning”) 
of sodium (but also of potassium, acid/base and water) excretion takes place at 
the level of the collecting duct. Accordingly, the collecting system may absorb 
between 3 and 5 % of the filtered sodium. 
The collecting duct consists of a tight epithelium, displaying an exclusively high 
transepithelial electrical resistance and very low paracellular water permeability. 
Morphologically, the epithelia lining the collecting duct consist of two cell types; the 
segment-specific cells (principal cells) and the intercalated cells, which disappear 
in the medullary parts of the duct (Figure 7.). The latter cells have the ability to 
secrete and/or reabsorb protons and bicarbonates, being responsible for the 
regulation of the acid/base balance, whereas sodium and water reabsorption and 
potassium secretion originates in the principal cells. 
 
Figure 7. Schematic representation of 
the segment specific cell of the cortical 
collecting duct (CCD), showing apical and 
basolateral transport pathways for 
sodium. 
Adapted from www.kidneyatlas.org/. 
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In the principal cells the sodium reabsorbing machinery is formed by the apical 
epithelial sodium channel ENaC and the basolaterally located Na+,K+-ATPase 
(Figure 3.). By extruding 3 Na+ to the blood side in exchange for 2 K+, the Na+,K+-
ATPase generates the driving force for Na+ entry via ENaC. Because the sodium 
reabsorption is electrogenic (both apical and basolateral transport systems), a 
large lumen-negative transepithelial voltage (-10 to -60 mV) is generated. As Na+ 
reabsorption decreases further down the collecting duct, the transepithelial voltage 
decreases and turns slightly lumen positive. The main extrusion of potassium from 
the intracellular compartment of CCD cells to the tubular lumen is provided by 
ROMK, an inwardly rectifying potassium channel [8]. Potassium secretion is 
favored by depolarization due to apical Na+ entry. The CCD is also important for 
the water reabsorption that occurs via the apical vasopressin- induced water 
channel aquaporin 2 (AQP-2), the constitutively expressed basolateral water 
channels aquaporin 3 (AQP-3) and by aquaporin 4 (AQP-4). Moreover, the 
basolateral membrane contains a Na+/H+ exchanger (NHE-1), which is involved in 
intracellular pH regulation [9]. 
In general, sodium reabsorption in the segment-specific cells of the collecting 
duct of the ASDN is performed mainly via amiloride sensitive sodium channels 
(ENaC). 
 
1.2.7. The Ureter 
The ureters are muscular tubes, which carry urine from the kidneys to the 
bladder. The lumen of the ureter is heavily folded and is lined with transitional 
epithelium. 
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2. The Salt/Water Homeostasis and Blood Pressure Regulation 
 
Sodium is the predominant cation in extracellular fluid (ECF) and the volume of 
ECF is directly proportional to the content of sodium in the body. Impairment of 
sodium balance (homeostasis), therefore, may be viewed as disorders of ECF 
volume. The body must maintain ECF volume within acceptable limits to maintain 
tissue perfusion because plasma volume is directly proportional to ECF volume. 
The plasma volume is a crucial component of the blood volume that determines 
rates of organ perfusion. ECF volume is maintained within narrow limits despite 
wide variations in dietary sodium intake. 
Goldblatt and later in the early 80’s Guyton et al. [10] demonstrated the 
importance of the kidney in controlling the arterial pressure. Many mechanisms are 
involved in the acute regulation of pressure homeostasis, such as endogenous 
regulators of vascular tone, hormonal vasoconstrictors, neural inputs, and other 
nonrenal mechanisms. The long-term regulation of arterial pressure is intimately 
linked to the ability of the kidneys to retain/excrete sufficient sodium chloride to 
maintain normal sodium balance (net intake = net loss [11]), extracellular fluid 
volume (ECF) and blood volume at normotensive arterial pressures. Blood 
pressure (BP) is controlled by renal volume excretion, which is adjusted to a set 
point. 
 
Figure 8. Volume determinants of 
arterial pressure. The two major 
determinants of arterial pressure, 
cardiac output and total peripheral 
resistance, are regulated by a 
combination of short- and long-
term mechanisms. 
Adapted from Navar [12]. 
 
 
 
 
 
 
 
 
In normal persons, an increased intake of sodium chloride leads to appropriate 
adjustments in the activity of various humoral, neural, and paracrine mechanisms 
(Figure 8.). These mechanisms alter systemic and renal hemodynamics and 
increase sodium excretion without increasing arterial pressure [12, 13]. 
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Glomerular filtration rate (GFR), GFR-independent natriuretic factors and 
importantly the renin-angiotensin-aldosterone system affect sodium homeostasis. 
The precise control of BP occurs via Na+ homeostasis and involves the precise 
regulation of ENaC in the aldosterone-sensitive distal nephron (ASDN). This has 
been corroborated by the linkage of mutations in the genes encoding ENaC 
subunits and Liddle’s syndrome, an inheritable form of human hypertension. 
Mapping of these mutations on the ENaC gene indicated that inactivation of PY 
(proline rich) motifs is responsible. These observations lead to the hypothesis that 
the channel interacts, via its PY motifs, with the WW domains of ubiquitin-protein 
ligases of the Nedd4/Nedd4-like family. It is now well established that the cell 
surface expression of ENaC is controlled via ubiquitylation by members of this 
protein family and that ubiquitylation is regulated by the aldosterone-induced 
protein serum and glucocorticoid induced kinase 1 (SGK1) [14]. The relationship of 
Renin-Angiotensin-Aldosterone-System-BP-Regulation via ENaC and the 
involvement of several other gene products will be decribed in the following 
chapters. 
 
2.1. The Renin-Angiotensin Aldosterone System (RAAS) 
The RAAS plays an important role in regulating blood volume, arterial pressure, 
cardiac and vascular functions. The importance of this system is best illustrated by 
considering the response to lowered blood pressure (Figure 9). When the rapid 
nervous response, acting via vasoconstriction, is insufficient to bring the blood 
pressure back to the normal values, then hormonal control of the total body fluids 
must also occur. Renin, generated from prorenin, is released from cells of the 
juxtaglomerular apparatus of the kidneys, and circulates throughout the body. 
Renin secretion is inhibited by increases, and stimulated by decreases in 
intracellular calcium (Ca2+) concentration. Voltage-sensitive Ca2+ channels in the 
plasma membrane are activated by membrane stretch, which correlates with 
arterial pressure and is assumed to mediate inhibition of renin secretion. Renin 
secretion is also stimulated when the concentration of Na+ and Cl- at the macula 
densa decreases [15, 16] or due to sympathetic discharge. 
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Renin catalyses the proteolytic cleavage of angiotensinogen, which is 
constitutively, secreted by the liver, forming the decapeptide angiotensin I (AI). 
Eventually, angiotensin I reaches the lungs where angiotensin converting enzyme 
(ACE) cleaves two amino acids to form the active octapeptide, angiotensin II (AII). 
 
Figure 9. Schematic representation of the 
positive and the negative feedback loops of 
the renin-angiotensin-aldosterone system 
(RAAS). 
SVR = systemic vascular resistance 
Adapted from www.kidneyatlas.org. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Angiotensin II carries out various functions: First, it induces vasoconstriction 
that leads to an increase in blood pressure and, subsequently, to an increase in 
renal blood flow and glomerular filtration rate (GRF). Second, it activates the 
biosynthesis of the mineralocorticosteroid hormone aldosterone in the adrenal 
gland (Figure 9). The resulting increase in aldosterone level is then responsible for 
the stimulation of the Na+ reabsorbing machinery in aldosterone-responsive cells. 
The principle of aldosterone action is the retention of sodium. Where sodium 
goes, so follows the associated ions and water. Therefore, aldosterone profoundly 
affects fluid balance by affecting extracellular fluid volume. Aldosterone acts on the 
responsive segment specific cells localized in the distal nephron causing an 
increase in sodium reabsorption (see next paragraph). As a result, the tissue 
concentration of Na+ in this area increases. Water reabsorption from the collecting 
duct depends on the surface expression of the ADH-sensitive AQP2 and is driven 
by simple osmosis due to high Na+ and urea concentration of the surrounding 
tissue. The resulting increase in the body water also affects the blood pressure 
increasing it to normal level. 
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2.2. Aldosterone, Aldosterone Sensitive Distal Nephron (ASDN), 
Mineralocorticoid Receptor (MR) and Transepithelial Na+ Transport 
Aldosterone is a steroid hormone and belongs to the subgroup of 
mineralocorticoid hormones. It is secreted from the adrenal cortex after stimulation 
by the renin-angiotensin system (RAAS), kalaemia and, to some extent, ACTH. As 
for other steroid hormones, it binds to a cytosolic receptor and the complex then 
translocates to the nucleus where it increases or represses the expression of 
target genes via binding to hormone response elements (HRE) (i.e. SGK1). These 
receptors are members of the family of ligand-activated nuclear hormone 
receptors. 
Two types of steroid receptors that bind aldosterone have been identified a 
type I receptor (mineralocorticoid receptor; MR), which is restricted to aldosterone 
responsive tissues and a type II receptor (glucocorticoid receptor; GR) [17-19]. 
Aldosterone binds with a high affinity (Kd ~1 nM) to the MR and with a low affinity 
to the GR (Kd ~50 nM). The enzyme 11-β-hydroxysteroid dehydrogenase type 2 
(11-β-HSD-2) modifies glucocorticoids that also exhibit a high affinity for the MR, in 
the aldosterone target cells, thus providing a mechanism to protect the MR from 
glucocorticoid action (Figure 10.). 11-β-HSD-2 transforms cortisol (dominant 
glucocorticoid in humans; corticosterone: dominant glucocorticoid in rodents) into 
its corresponding cortisone [20], which has a much lower affinity for the MR. At 
high concentrations (10-7-10-6 M) aldosterone binds to the GR and exerts specific 
actions. In A6 cells as well as mpkCCDc14 cells for example, most of the 
aldosterone effect is exerted via the GR. 
The nephron portion that responds to aldosterone is referred to as ASDN, 
standing for Aldosterone Sensitive Distal Nephron. Morphologically, it contains the 
second half of the distal convoluted tubule (DCT2), the connecting tubule (CNT), 
the cortical collecting duct (CCD) and the medullary collecting duct (MCD). The 
aldosterone-responsive cells, or the segment-specific cells, are functionally 
defined as those expressing ENaC, the mineralocorticoid receptor (MR) and the 
enzyme 11β-HSD2. These segments are the site where the fine-tuning of the final 
urinary Na+ excretion takes place. The Na+ reabsorbing machinery is formed by 
apically located ENaC, which mediates Na+ influx, and by the Na+,K+-ATPase, that 
extrudes Na+ across the basolateral membrane to the blood side. 
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Aldosterone controls Na+ reabsorption by regulating both the short- and long-
term expression of both transport proteins. Additionally both transporters are 
regulated by a complex network of local factors (Figure 11.). 
 
Figure 10. Simplified scheme of the 
principal cell (segment specific cell) 
of the ASDN with the epithelial 
sodium channel (ENaC), the 
Na+,K+-ATPase, the mineralo-
cortiocid receptor (MR) and 11β-
HSDS2 
Adapted from www.kidneyatlas.org. 
 
 
 
 
 
 
 
The electrochemical gradient, i.e. the driving force for sodium influx, is 
maintained by the activity of the basolaterally located Na+,K+-ATPase and the K+ 
conductance of both membranes. 
Functional and morphological studies [21, 22] clearly indicated that in rats and 
probably also in humans, the ASDN is composed of the late portion of the distal 
convoluted tubule (DCT2), in which ENaC is co-localized with the DCT-specific 
thiazide-sensitive sodium chloride co-transporter, the connecting tubule (CNT), as 
well as the cortical and the medullary part of the collecting duct, respectively. All 
along the ASDN, intercalated cells are interspersed between the sodium 
transporting segment-specific cells, termed DCT cells, CNT cells and the collecting 
duct cells (also called principal cells). In contrast to the segment-specific cells, the 
intercalated cells show different characteristics and play a role in proton and 
bicarbonate secretion and/or reabsorption. 
Aldosterone has the opposite effect on serum levels of potassium than of 
sodium since to a large extent potassium is excreted in exchange for sodium that 
is reabsorbed via ENaC. Salivary and sweat glands as well as the distal colon 
respond to aldosterone to prevent excessive sodium loss. Aldosterone levels can 
increase fluid retention in diseases such as congestive heart failure and liver 
cirrhosis. Certain diuretics act by antagonizing aldosterone. In contrast to most 
diuretics which cause potassium loss, the aldosterone antagonists, i.e. K+ sparing 
diuretics, increase blood potassium and are sometimes used to accomplish this 
effect. 
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2.3. The Early and Late Effects of Aldosterone in the ASDN 
The best known action of aldosterone in ASDN cells is to increase the ENaC 
mediated sodium conductance at the apical membrane and the activity of the 
Na+,K+-ATPase pump in the basolateral membrane. The action of aldosterone has 
been operationally divided into three physiologically more or less distinct phases, 
which are: 
1) a latent period of less than 30 minutes, where the initial changes in gene 
transcription and protein synthesis starts; 
2) an “early response” period, with a 2- to 3- fold increase in sodium 
reabsorption within 3 hours of aldosterone action mainly due to the 
increased activity of pre-existing ENaC and Na+,K+-ATPase [23, 24]; 
3) a “late response” period of up to 24 hours with not only a further increase in 
the activity of ENaC but also that of the Na+ pumps. 
 
However, this division is schematic and does not appear to be appropriate for 
the in vivo situation in mammals. First, this operational division is only meaningful 
in extreme conditions such as those imposed in experimental situations (all or 
none situation). Second, ENaC subunit upregulation that occurs in the early phase 
(see below) is an ‘anabolic type’ effect. Finally, the concept of anabolic response is 
also applicable to the induction of regulatory proteins, because these proteins 
represent constitutional elements of regulatory cascades. 
Undeniably, aldosterone induces compared to a substantial increase of α-
ENaC protein abundance a modest increase in the α-ENaC subunit mRNA 
expression but does not affect the mRNA expression of the β- and γ-ENaC subunit 
in the rat and mouse CCD [25-27]. The rapid effect of aldosterone on ENaC is 
probably due to the observed increase in the insertion of channels in the apical 
membrane [25, 27, 28]. 
The connection between the activated hormone/receptor complex and the 
ultimately higher ENaC conductance has remained obscure until the identification 
of SGK1 (Figure 11.). 
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Figure 11. Schematic representation of regulatory pathways participating or modulating the 
aldosterone action in segment-specific cell of the aldosterone-sensitive distal nephron The thick 
arrows indicate transcriptionally mediated inductions by aldosterone of gene products which impact 
on sodium reabsorption via the epithelial sodium channel (ENaC). Medium arrows indicate 
regulatory pathways, the importance of which are established in the context of sodium 
reabsorption. Medium arrows are stippled when the precise site of impact or the existence of 
intermediate steps is not established. Thin, stippled arrows indicate pathways that have been 
described in other cell types and might modulate aldosterone action in the aldosterone-sensitive 
distal nephron (ASDN). AC, Adenylyl cyclase; ADH, anti-diuretic hormone (vasopressin); cAMP, 
cyclic adenosine 3’,5’-monophosphate; ERK, mitogen-activated protein kinase (MAPK) of ERK 
(extracellular signal-regulated kinase) type; FGF, fibroblast growth factor; GS, trimeric G-protein αS 
subunit; 11βHSD2, 11-β-hydroxysteroid dehydrogenase type 2; IGF, insulin-like growth factor; 
IRS1, insulin receptor substrate 1; MKK, MAPK kinase; MR, mineralocorticoid receptor; p38, MAPK 
p38; PDGF, platelet-derived growth factor; PDK, phosphoinositide-dependent kinase; PI3-K, 
phosphoinositide 3-kinase; PKA, protein kinase A; TGFβ, transforming growth factor; V2, 
vasopressin receptor type 2. Note the regulatory pathway that links the transcriptional regulation of 
SGK1 to the cell-surface expression of ENaC via Nedd4-2. 
Adapted from Loffiing et al. [326]. 
 
The coexpression of SGK1 with the three ENaC subunits in the Xenopus laevis 
oocytes produces much higher amiloride inhibitable currents than occur in the 
absence of co-expression [29-32]. 
Other substances, such as hormones and intracellular factors like pH, calcium, 
regulatory proteins, can also affect ENaC conductance on several levels, i.e. via 
mRNA expression, protein synthesis and degradation, cellular distribution and 
(possibly) function. One interesting possible regulatory factor is the channel 
activating protease (CAP) [33]. 
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Corticosteroids, such as aldosterone and dexamethasone, have been shown to 
have both short- and an long-term effects on the Na+,K+-ATPase. The long term 
increase in pump activity observed in several model systems is mediated by an 
increase in Na+,K+-ATPase pump expression [34-36]. The corticosteroid 
hormone/receptor complex interacts directly with regulatory elements of both the 
α1 [34] and β1 subunit genes [37]. Aldosterone has also short-term effects on 
pump activity. This effect can be mediated by an increase in the amount of Na+ in 
the cell, via its entry through ENaC. Since it is a rate limiting substrate, intracellular 
Na+ ([Na+]i) then stimulates the activity of the Na+,K+-ATPase [35, 38]. In addition, 
it might also prompt the translocation of the Na+,K+-ATPase pump to the plasma 
membrane [39]. On the other hand, aldosterone can also mediate the upregulation 
of Na+,K+-ATPase in A6 cells [40, 41], independent of Na+ influx, in a transcription- 
and translation-sensitive manner. 
K-Ras2 [42] might also play an important role in the increase in overall Na+ 
reabsorption but the mechanism of action has not yet been shown. K-Ras possibly 
activates lipid kinases causing an increase in phosphatidyl-inositol-2 phosphate 
(PIP2) [43] which has been shown to stimulate ENaC in excised membrane 
patches of A6 cells [44]. Another possibility is that the traditional Ras effector, Raf 
kinase, might stimulate MKK (MAPK kinase) which then acts as upstream 
regulator of SGK1. Furthermore, Ras can also activate PI3 kinase which acts on 
SGK1 activity via PDK1. Cell-specific differences may occur. 
As depicted in Figure 11., several signaling pathways affect the function of 
ENaC via other receptors in response for instance to IGF1 [45], insulin, PDGF, 
ADH and FGF. Ultimately cross-talk among various signalling pathways will have 
to be considered in order to understand the overall context in which aldosterone 
exerts its action. Such approaches have already been attempted and will be 
considered in the discussion section of the thesis. 
In the following chapters some key gene products, ENaC, Na+,K+-ATPase, 
SGK1 and Nedd4-2 of the scheme shown in Figure 11. will be described in detail. 
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2.3.1. The Epithelial Sodium Channel (ENaC) 
ENaC is a member of the DEG/ENaC family of ion channels. Individual 
members of this family have diverse functions, which include mechanosensation, 
proprioception and salt regulation [46]. ENaC is an important regulator of Na+ 
homeostasis and thus plays a major role in maintaining extracellular volume and 
blood pressure. It is expressed in the kidney distal nephron and in the renal 
collecting duct, where it regulates urinary Na+ excretion, which is important for 
maintaining a balance of fluids, Na+ and other electrolytes in the body. ENaC is 
responsible for active Na+ reabsorption in epithelial tissues such as the renal 
segment-specific cells of the CNT/CCD, the distal colon (under the control of 
aldosterone), the lung, the parotid gland  and the sweat- and salivary-ducts [47]. It 
is localized to the apical membrane of polarized epithelia and it shows axial 
heterogeneity along the ASDN. Its expression is most pronounced in the early 
ASDN portions (late DCT and early CNT) and expression progressively decreases 
in downstream segments (late CNT and CD) [26, 27]. The ENaC protein 
expressed in the distal colon and sweat- and salivary-ducts functions to reduce the 
amount of Na+ loss [47]. In the lung, ENaC maintains the correct composition of 
the fluid that lines lung epithelia, especially during the transition from liquid-filled to 
air-filled neonatal lung [47, 48]. Na+ transport through ENaC occurs by electro-
diffusion rather than by coupling with transport of co-solutes or through an energy-
dependent process. ENaC function can be blocked by amiloride, a K+-sparing 
diuretic [47, 49]. Functional ENaC is generally composed of three homologous 
subunits, named α, β and γ. Similar to other DEG/ENaC family members, each 
ENaC subunit (Figure 12.) has a conserved protein structure, consisting of two 
hydrophobic trans-membrane regions (TM1, TM2), an large extracellular loop with 
highly conserved cysteine residues, and short intracellular amino and carboxyl 
termini [46, 50, 51]. 
The subunit stoichiometry of functional plasma membrane-associated ENaC is 
controversial. However studies have provided evidence that support a tetrameric, 
2α:1β:1γ [52-54], or lately a trimeric [55] stoichiometry. The α subunit was first 
cloned from rat by two independent groups, who both identified a cDNA encoding 
a predicted molecular mass of 79 kDa protein [56, 57]; later the β and γ rat ENaC 
subunits were cloned by Canessa et al. [58]. It was found that injection of Xenopus 
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oocytes with all three subunits resulted in an amiloride-sensitive Na+ current more 
than 100-fold larger than that of αENaC alone. Therefore, fully functional ENaC 
consists of all three subunits [58]. 
 
 
Figure 12. Schematic representation 
of the ENaC channel in the 
membrane. (Left) Secondary 
structure predictions and membrane 
topology of one ENaC subunit. 
(Right) ENaC channel model. 
Cylinders represent putative α 
helices. P, extracellular pore helix; 
HG, conserved His and Gly residues 
among all of the members of the 
ENaC/degenerins family members; 
P.Y, PY motif common to the αβγ-
ENac subunits; DEG, degenerin site 
in the P-helix. 
Adapted from Gramling Medical 
Illustration. 
 
 
 
Proline-rich motifs are found in the C-terminus of the αβγENaC subunits [59], in 
particular a PPxY sequence (PY motif) that represents a characteristic pattern for 
WW peptide ligands, like Nedd4-2, an ubiquitin ligase, exhibits. These PPxY 
sequences in the β and γENaC subunits are the target sequence for mutations that 
cause Liddle’s syndrome (pseudohypoaldosteronism) [60-62]. Nedd4-2 catalyzes 
the attachment of ubiquitin moieties on the channel for endocytosis and 
degradation. Mutations in the PY motif alter this process [63]. When ENaC gets 
ubiquitylated, multiple lysine residues in the N-termini of α (K47 and K50) and γ 
subunits (K6 to K13) are substrates for attachment of the ubiquitin moieties [64]. 
The importance of each individual ENaC subunit is supported by the 
corresponding mouse knockout phenotypes. α-, β- and γENaC knockout mice die 
shortly after birth from a failure to clear lung fluid (α ENaC, [65]), show increased 
urinary Na+ but normal lung fluid clearance (βENaC, [66]) and have electrolyte 
disturbances and a minor lung fluid clearance defect (γENaC, [67]). 
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2.3.1.1. ENaC Regulation 
ENaC activity must be tightly regulated since it is the rate-limiting step in Na+ 
absorption in tissues such as the kidney. ENaC is located on the apical membrane 
allowing the entry of Na+ into the cell, which then exits the cell through the 
basolaterally located Na+/K+ ATPase [68]. 
Typically ENaC shows a unitary conductance of 4-5 pS for Na+ [58, 69, 70] and 
of 9-10 pS for Li+ [58, 69]. It also shows a strong selectivity of Na+ over K+. 
ENaC regulation occurs by changing the channel open probability (Po) and/or 
altering the number of channels at the plasma membrane. The latter appears to be 
more important in controlling Na+ absorption. A number of hormonal and non-
hormonal mechanisms regulate ENaC density at the plasma membrane. 
Hormones which regulate ENaC include aldosterone, insulin and vasopressin [47]. 
Non-hormonal regulation of ENaC can occur in response to changes in ion 
concentrations, by the cystic fibrosis transmembrane conductance regulator 
(CFTR) and by proteases [47, 48]. 
In the kidney, ENaC is highly regulated by various hormonal pathways, such as 
those linked to aldosterone, vasopressin, and insulin [71]. Although in recent 
years, considerable progress has been made in understanding the regulatory 
action of hormones many of the molecular mechanisms involved remain unsolved. 
Genetic evidence supports the current view that ENaC expression and activity is 
regulated via ubiquitylation and phosphorylation [14]. 
 
2.3.1.2. Hormonal Regulation of ENaC 
The molecular mechanisms by which hormones regulate ENaC activity can be 
classified as: (1) change of the number of channel molecules expressed at the 
plasma membrane, (2) change of the open probability (Po) of the channel, and (3) 
change of the unitary conductance of the channel [72]. The most likely candidate 
proteins that could up-regulate ENaC activity by their increased synthesis are the 
ENaC subunits themselves, but this is considered to be a late response that is 
initiated 6-24 hours following aldosterone stimulation [47, 73]. Furthermore, 
increased ENaC subunit synthesis does not include all subunits; rather the effect 
is tissue-specific with increased αENaC in the kidney and increased β and γENaC 
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mainly observed in the distal colon [74-76]. 
An effort to identify in Xenopus laevis A6 cells genes that are up-regulated 
during the early response to aldosterone stimulation, [42]) identified the small G 
protein KRas2A. It was subsequently shown that K-Ras2A over-expression in 
Xenopus kidney cells (A6) significantly increased the inward movement of Na+ 
[77]. A direct role for K-Ras2A-mediated Na+ channel activation remains to be 
determined [78]. Another study has shown that aldosterone can stimulate 
carboxymethylation of βENaC and this may increase ENaC activity [79]. 
Another possible avenue for ENaC stimulation by aldosterone is via the 
signaling molecule phosphoinositide 3-kinase (PI3-K). It has been shown that PI3-
K is required for aldosterone-stimulated sodium reabsorption. ENaC stimulation 
may occur via the activity of the PI3K phosphorylation targets; phosphatidylinositol 
3,4-bisphosphate (PtdIns(3,4)P2) and phosphatidylinositol 3,4,5-trisphosphate 
(PtdIns(3,4,5)P3) [80]. Recent evidence suggests that PtdIns(3,4)P2 and 
PtdIns(3,4,5)P3 affect ENaC activity by increasing channel Po [81]. It has also 
been shown that the PI3-K signalling pathway activates SGK1 by phosphorylation 
[82, 83]. From this it would appear that aldosterone potentially activates SGK1 by 
increasing transcription and by the PI3-K pathway-mediated phosphorylation of 
SGK1 [78]. 
The insulin-like growth factor 1 (IGF-1) [45, 84] and the peptide hormone insulin 
[47] are known to activate Na+ channels in a variety of epithelial cells. They 
function by binding to the IGF-1-receptor or insulin receptor respectively, which 
triggers intracellular signalling. Studies have provided evidence of insulin-
stimulated Na+ channel activation being mediated by protein kinase C (PKC) [85] 
and PI3-K [86], and IGF-1 dependent Na+ channel activation by PI3-K [45]. A role 
for kinase-mediated ENaC stimulation in response to insulin is further bolstered by 
the finding that insulin stimulation leads to β and γENaC phosphorylation [87]. 
Insulin stimulation has been proposed to affect ENaC activity by increasing the Po 
[88] and by increasing ENaC density at the plasma membrane [89, 90]. The 
finding that the PI3-K pathway is stimulated by aldosterone, insulin and IGF-1 has 
led to suggestion that ENaC stimulation by those hormones may be carried out by 
SGK1 [91]. 
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Vasopressin is a peptide hormone that increases Na+ channel activity as 
rapidly as 5 minutes following stimulation. Following binding to its V2 receptor, 
adenylate cyclase is activated, which results in the production of the second 
messenger cyclic AMP (cAMP). cAMP is believed to activate kinases that are able 
to up-regulate ENaC activity by an unknown mechanism. It has been suggested 
that this can occur by increasing the channel density at the plasma membrane and 
by increasing the Po [47]. 
 
2.3.1.3. Non-hormonal Regulation of ENaC 
Na+ feedback inhibition is a well-characterised mechanism of ENaC down-
regulation. In addition to intracellular Na+, Ca2+, pH, anions and extracellular Na+ 
have also been implicated in the control of Na+ channel activity [47, 92]. Strong 
evidence for an inhibitory action of increased intracellular Na+ on Na+ channels 
was reported by Komwatana et al. [93]. 
Nedd4 has been found to down-regulate ENaC via its specific interaction with 
binding sites on channel subunits which are mutated in Liddle’s syndrome [63, 94]. 
A detailed presentation of this pathway will be given in later chapters. 
CFTR secretes Cl- in response to cAMP and is known to affect ENaC activity. It 
was shown by Mall et al. [95] that CFTR down-regulates ENaC in normal human 
lung epithelia, but not in the lung epithelia of cystic fibrosis patients that have 
mutant CFTR. It has been suggested that CFTR and ENaC physically interact 
thereby eliciting regulatory effects [96]. It has also been proposed that various 
CFTR accessory proteins might facilitate regulatory interactions with ENaC [97]. 
To be fully active, ENaC requires considerable post-translational modifications, 
including proteolytic cleavage. It has been shown that in ENaC-expressing 
epithelia only a very small proportion of ENaC is expressed on the plasma 
membrane, with a majority of the channel subunits residing in pre-golgi 
compartments as immature forms where they await degradation [98]. Subunits are 
glycosylated at a number of sites in the extracellular loop, but during translocation 
to the plasma membrane these modifications undergo complicated processing 
[99]. 
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Further, it was shown that proteolytic cleavage of the α and γ subunits is 
another important step in the maturation of ENaC. The cleavage sites are located 
in the extracellular loop, near the amino-membrane-spanning domain for each 
subunit, with the resulting fragments remaining associated with the channel [100]. 
It was subsequently found that the proprotein convertase, furin, is responsible for 
cleavage of the α and γ subunits, which up-regulates ENaC activity [101]. 
Another protease, channel-activating protease 1 (CAP1), has been shown to 
increase ENaC activity [33]; however, it is not known whether it functions by 
cleaving ENaC or another regulatory protein. There is also evidence that CAP1 
(prostasin) is induced by aldosterone [102]. 
 
2.3.2. The Na+,K+-ATPase 
The basic function of Na+,K+-ATPase is to maintain the high Na+ and K+ 
gradients across the plasma membranes of most higher eukaryotic cells. For its 
activity the pump uses the energy from the hydrolysis of the phosphate bond in the 
ATP. The ion gradient that results from its function plays an important role as the 
driving force for a variety of Na+ dependent secondary transporters, like those of 
glucose and amino acids, and enables the K+ conductance to stabilize the 
membrane potential close to the K+ Nernst potential. 
The minimal functional unit of the Na+,K+-ATPase is an oligomer composed of 
stoichiometric amounts of either of the α (α1, α2, α3 or α4) and either of the β (β1, 
β2 and β3) subunit isoforms. Whereas the α subunit possesses 10 predicted 
transmembrane domains and a mass of 112 kDa, the β subunit polypeptide is a 
type II membrane protein with a single transmembrane domain that exhibits a 
molecular weight between 40 and 60 kDa. The two subunits differ in their roles, 
the α-subunit being the actual catalytic subunit. The additional γ subunit has a 
molecular weight of only 8-14 kDa and belongs to a family of small membrane 
proteins that appear to modulate the passage of ions across the plasma 
membrane. The γ subunit is not required for normal Na+,K+-ATPase activity [103] 
but nevertheless it seems to modify the sodium/potassium affinity of the enzyme. 
The hypothesis, that SGK1 is also involved in Na+,K+-ATPase regulation was 
confirmed in Xenopus laevis oocytes, since it was demonstrated, that SGK1 
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increases the activity of the Na+,K+-ATPase by increasing its cell surface 
expression [104, 105]. 
CHIF, a small protein related to the γ subunit, has been shown to localize to the 
basolateral membrane of segment-specific cells of the ASDN. It represents an 
example of the differential aldosterone action in kidney ASDN versus the distal 
colon. In contrast to the colon, CHIF is not regulated by aldosterone in the kidney 
ASDN but rather by a low sodium diet. Its role in the context of aldosterone action 
remains unclear, but indirect evidence points to a regulatory function in epithelial 
potassium transport [106]. 
 
2.3.3. The Serum- and Glucocorticoid induced Kinase (SGK1) 
SGK1 was originally identified as a kinase that is inducible by serum and 
glucocorticoids and belongs to the early aldosterone-induced gene products in 
kidney (ASDN) [14]. It is a member of the AGC (cAMP dependent, cGMP 
dependent, and protein kinase C) family of Ser/Thr kinases and shares 
approximately 50% identity in its catalytic domain with other AGC kinases such as 
protein kinase A, Akt, or protein kinase C [107]. There are two close homologues, 
SGK2 and SGK3 (or CISK), that share approximately 80% sequence identity with 
SGK1 [108, 109]. They also share a high degree of similarity with Akt/protein 
kinase B. SGK1 was one of the first early aldosterone-induced gene products 
detected in renal epithelial cells [26, 29, 31, 110-113]. 
Interest in SGK1 was considerable because it stimulates ENaC activity in 
oocytes [26, 29, 31, 91, 110, 114-120]. This increase in ENaC activity was shown 
to be mostly due to elevated channel cell surface expression [26, 115, 116, 119], 
although one report also observed an effect on Po [118]. Further evidence for a 
role in epithelial Na+ transport came from transduction experiments in renal 
epithelial cells, which demonstrated that expression of SGK1 in various cell lines 
increased transepithelial Na+ currents [121-124]. 
Alvarez De La Rosa et al. [123] observed a 4-fold effect on ENaC cell surface 
expression as well as an increase of 43% in Po in A6 cells that were transduced 
with constitutive active SGK1. It is not clear how SGK1 stimulates the Po of ENaC, 
as the SGK1-dependent phosphorylation site on αENaC, described by Diakov et 
al. [125] below, is not conserved in Xenopus laevis αENaC. SGK1 activity is 
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known to be regulated by the phosphatidylinositol-3 kinase pathway and needs to 
be phosphorylated by PDK1, demonstrating that its function depends on the 
activity of this pathway. Indeed, evidence was provided by several groups that 
stimulation of Na+ transport by aldosterone and/or SGK1 is inhibited by 
phosphatidylinositol-3 kinase inhibitors [80, 91, 126]. Antisense [124], RNA 
interference [113], or overexpression of catalytically inactive SGK1 [121, 122, 124] 
further corroborates the role of SGK1 in positive regulation of transepithelial Na+ 
transport. The strongest evidence for such a function comes from the SGK1 
knockout mice, which present a pseudohypoaldosteronism type 1 phenotype when 
kept under low-Na+ diet [127]. 
 
2.3.3.1. Tissue distribution of SGK1 
SGK1 expression is induced by a very large spectrum of stimuli in addition to 
glucocorticoids and serum [128]. These include aldosterone [29, 110], TGF-β [120, 
129-131], vitamin D3 [132], glucose [131], endothelin-1 [131], granulocyte-
macrophage colony–stimulating factor (GM-CSF) [133], fibroblast growth factor 
(FGF) [134], platelet-derived growth factor (PDGF) [134], p53 [135-138] and many 
others. Sgk1 [107, 108, 139] is broadly distributed, with expression in many 
tissues, including the brain, placenta, lung, liver, pancreas, kidney, heart, and 
skeletal muscle. In situ hybridization studies localized Sgk1 mRNA in several 
epithelial and/or nonepithelial cells within the brain [140-144], eye [145, 146], lung 
[147], liver [130], ovary [148], pancreas [149], intestine [129], and kidney [29, 150, 
151]. 
The aldosterone-dependent induction of Sgk1 occurs specifically in the 
cytoplasm of ENaC-positive cells of the ASDN, whereas Sgk1 expression in other 
nephron portions such as the thick ascending limb or the proximal tubule is not 
increased by aldosterone [27]. The subcellular localization is consistent with the 
reported intracellular localization of Sgk1 in stably transfected CCD cells [152], in 
mammary tumor cells expressing exogenous or endogenous Sgk1 [153], and in C. 
elegans expressing GFP-tagged SGK1 [154]. 
It is important to note that the subcellular distribution of Sgk1 may change 
according to the stimulus received. Sgk1 can be localized to the nucleus, to the 
cytoplasm and/or at the plasma membrane [148, 153, 155-157]. 
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2.3.3.2. Mechanisms of SGK1 Action 
Several mechanisms have been proposed for SGK1-dependent regulation of 
ENaC. Wang et al. [91] showed that SGK1 directly interacts with the C-terminus of 
βENaC. Diakov et al. [125] identified a consensus phosphorylation site on the C-
terminus of αENaC (S621) and found by the outside-out patch-clamp technique 
and inclusion of recombinant SGK1 in the pipette that this site may be important for 
ENaC stimulation. However, mutation of this site to alanine (S321A) does not 
impair the stimulatory effect of SGK1 (as well as of SGK2 and SGK3) on amiloride-
sensitive Na+ currents in Xenopus laevis oocytes [158]. Demonstration that αENaC 
indeed becomes phosphorylated by SGK1 will be required to shed some light on 
this mechanism. 
An alternative model proposes that Nedd4-2 is a substrate of SGK1, as Nedd4-
2 contains three consensus phosphorylation sites for SGK1 [114, 115], and SGK1 
itself contains a PY motif, rendering it possible that SGK1 and Nedd4-2 interact via 
a PY motif/WW domain (Figure 13.). 
Figure 13. Model of regulation of the 
ENaC by Sgk1 and Nedd4-2. Induction of 
aldosterone leads to the expression of 
Sgk1. Sgk1 interacts via PY motif/WW 
domains with Nedd4-2 and 
phosphorylates Nedd4-2 on Ser444. 
Phosphorylated Ser444 serves as binding 
site for 14-3-3, which hinders interaction 
of Nedd4-2 with ENaC. This interferes 
with ENaC ubiquitylation, internalization, 
and degradation in the lysosomal 
pathways, consequently leading to 
accumulation of ENaC at the cell surface. 
Adapted from Gramling Medical 
Illustration (Staub and Verrey). 
 
 
 
 
 
In support, it was demonstrated that SGK1 does interact with Nedd4-2 [114, 
159] and that the PY motif on SGK1 is partly required for SGK1-dependent 
stimulation of ENaC in Xenopus laevis oocytes [115]. In oocytes, it was also shown 
that SGK1 induces phosphorylation of Nedd4-2 on two sites, primarily on Ser444 
but also on Ser338. Moreover, mutation of these sites interfered with SGK1-
dependent phosphorylation of Nedd4-2 and stimulation of ENaC [115]. 
Introduction  41 
It was further demonstrated that SGK1 reduced the interaction between Nedd4-
2 and ENaC, indicating that SGK1 impairs ENaC ubiquitylation and subsequent 
internalization. 
Taken together, these data suggest that one of the mechanisms by which 
aldosterone regulates ENaC function is by transcriptionally inducing SGK1 that in 
turn phosphorylates Nedd4-2. As expected from such a mechanism, the 
phosphorylation of Nedd4-2 on Ser444 is increased upon aldosterone treatment in 
mpkCCDc14 cells and in adrenalectomized rats [126]. When phosphorylated, 
Nedd4-2–Ser444 is part of a consensus binding site for 14-3-3 proteins, 
suggesting that it is the binding of 14-3-3 proteins to Nedd4-2 that sterically 
interferes with the interaction of Nedd4-2 with ENaC and prevents ENaC 
ubiquitylation [117]. Bhalla et al. (2006) [160] showed that 14-3-3 proteins bind to 
phosphorylated Nedd4-2 and interfere with Nedd4-2/ENaC interaction and ENaC 
ubiquitylation. 
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3. Ubiquitylation 
 
Ubiquitin is a highly conserved 76 amino acid protein expressed in all 
eukaryotes. Ubiquitin is covalently linked to protein substrates in a tightly regulated 
form of post-translational modification known as ubiquitination, or ubiquitylation. 
This can occur as: mono-ubiquitylation, the attachment of a single ubiquitin 
molecule to a position within the substrate; poly-ubiquitylation/multi-
monoubiquitylation, attachment of a chain of ubiquitin molecules to the substrate; 
or combinations of the two [161, 162]. The most well characterised consequence 
of ubiquitylation is substrate degradation, which occurs by either the proteasomal 
or lysosomal pathways [163]. A diverse array of proteins is down-regulated via 
ubiquitylation, such as cell cycle regulators, transcription factors, tumour 
suppressors, receptors and ion channels [162-165]. Another non-degradatory role 
of ubiquitylation appears to be in facilitating protein trafficking, which has emerged 
from the discovery of domains that undergo protein-protein interactions with 
ubiquitylated ligands [166]. 
Since the discovery of ubiquitin, a family of ubiquitin-like protein modifiers 
(UBLs) has been identified, which includes SUMO/Sentrin, Nedd8/Rub1, 
ISG15/UCRP and FAT10 [167, 168]. 
Ubiquitylation is a complex process involving three major classes of enzyme. 
Ubiquitin is first activated by an ubiquitin-activating enzyme (E1) in an ATP-
dependent manner, which results in the formation of a thioester bond between the 
ubiquitin carboxyl terminus and an internal cysteine of the E1 [169]. Ubiquitin is 
then transferred to the active cysteine of an ubiquitin-conjugating enzyme (E2) 
[165]. Following this, the E2-ubiquitin conjugate interacts with an ubiquitin-protein 
ligase (E3), which results in formation of an isopeptide linkage between the 
carboxyl terminal glycine of ubiquitin and, most commonly, a lysine residue within 
the substrate protein [164] 
Hundreds of E3 enzymes participate in substrate recognition [14]. These 
enzymes can be divided into two major protein families, namely the RING finger 
[170] and the HECT (homologous to E6-AP carboxyterminal) domain-containing 
proteins. Nedd4 belongs to the family of HECT domain ubiquitin-protein ligases 
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[171]. 
Poly-ubiquitylation results from the sequential attachment of ubiquitin 
molecules to lysine residues within ubiquitin molecules already attached to a 
substrate [165]. Of the seven lysine residues within ubiquitin, poly-ubiquitin chains 
are mostly linked through K48, but can also occur through K63, K29 or K11 [161, 
172]. Poly-ubiquitin chain formation through K48 is normally a signal for protein 
degradation by the proteasome, while chains formed through K63 are known to be 
involved in nondegradation functions [161, 172]. Besides involvement in protein 
trafficking, DNA repair and histone modification, mono-ubiquitylation and multiple 
mono-ubiquitylation are strongly implicated in endocytosis and lysosomal 
degradation [162, 173]. 
 
3.1. The Proteasomal and Lysosomal Degradation 
The proteasome is a large multi-catalytic complex responsible for the 
degradation of a majority of ubiquitylated soluble cellular proteins [174]. Typically, 
the proteasome degrades proteins containing poly-ubiquitin chains linked through 
K48, into short peptides [164]; however, certain non-ubiquitylated proteins can 
also be degraded by the proteasome [175]. The full-sized 26S proteasome is 
composed of three major complexes: a 20S cylinder-shaped catalytic core, with a 
19S regulatory complex at either ends [174]. 
Lysosomes are intracellular organelles that contain acidic proteases. The 
protein contents of late endocytosis vesicles can be delivered to lysosomes, 
resulting in their degradation [176]. The number of receptors, channels and 
transporters at the plasma membrane can be controlled via endocytosis and 
lysosomal degradation in response to changing cellular environments. Following 
ubiquitylation of such proteins, their endocytosis occurs via invagination of the 
local plasma membrane that eventually forms an intracellular membrane bound 
vesicle. Endocytosed membrane proteins may be simply recycled back to the 
plasma membrane or directed to the lysosomal degradation pathway. Plasma 
membrane proteins that are degraded in this way include the platelet-derived 
growth factor β, epidermal growth factor and growth hormone receptors, and 
ENaC [177]. 
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A common trigger for endocytosis of plasma membrane proteins is mono- 
ubiquitylation at an intracellular site, although in some cases a short ubiquitin 
chain linked through K63 is used [162]. Internalisation and lysosomal delivery are 
believed to be mediated by the action of ubiquitin-receptor proteins that recognise 
ubiquitylated proteins via ubiquitin-interacting protein domains [166, 173, 178]. In a 
similar way, ubiquitylation can also facilitate transport of newly synthesised 
proteins from the trans-golgi network to the lysosome for degradation [166, 178]. 
 
3.2. The Nedd4-family 
Nedd4 is a HECT domain ubiquitin-protein ligase [14]. These proteins are 
characterized by a C-terminal highly conserved 40-kD enzymatic HECT domain, 
and a variable, N-terminal region, which is involved in substrate recognition. The 
HECT domain contains a cysteine, which is essential for catalytic activity [171]. 
Nedd4 is the founding member of a subfamily of HECT enzymes, which contains 
nine members [179]. These enzymes are composed of an N-terminal (Ca2+-
dependent phospholipid binding) C2 domain [180], two to four WW domains [181], 
and the C-terminal HECT domain. They are involved in several different cellular 
functions [179, 182, 183]. The isolation of the WW domain containing Nedd4–1 
suggested that ENaC may interact with members of this family via its PY motifs. 
Upon interaction, Nedd4/Nedd4-like proteins may ubiquitylate one or several 
ENaC subunits, in analogy to many plasma membrane receptors [184], and cause 
their internalization and targeting to the endosomal multivesicular body pathway 
and ultimately degradation in the lysosome. 
Nedd4 was originally identified as a developmentally down-regulated mouse 
gene highly expressed in early embryonic central nervous system (CNS) [185]. It 
was subsequently found to be expressed widely in other embryonic and adult 
tissues [63, 186]. Other proteins were discovered in both simple and complex 
eukaryotes that share this domain architecture, which led to their classification as 
Nedd4-family member, or Nedd4-like, E3 proteins [183]. 
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3.2.1. The C2 Domain 
The C2 domain was first identified in protein kinase C and can function as a 
Ca2+-dependent phospholipid binding domain [187-189]. It consists of 
approximately 130 amino acids and is found in many proteins that function in 
signaling and membrane trafficking. A well studied C2 domain-containing protein is 
synaptotagmin I, which is found in synaptic vesicles and is required for Ca2+-
dependent neurotransmitter release. The C2 domain is a compact β-sandwich 
structure consisting of two four-stranded β-sheets, with three joining-loops at one 
end of the structure that bind Ca2+ [189]. The C2 domain of Nedd4 has been 
shown to mediate localisation to the plasma membrane in response to Ca2+ [190]. 
There are examples of C2 domains engaging in protein-protein interactions, such 
as the C2 domain of the Ras-specific GTPase activating protein, P120GAP, which 
has been shown to interact with a number of proteins [191]. The C2 domain of 
Nedd4 has also been shown to interact with the adaptor protein Grb10, in a Ca2+-
independent manner [192]. It has recently been reported that the C2 domain of 
Rsp5, the sole Nedd4-family protein in S. cerevisiae, is required for localisation to 
endosomal membranes [193]. The C2 domains of Nedd4-family proteins may be 
required to bring them in close proximity to substrates via associations with cellular 
phospholipids and by direct protein-protein interactions. 
 
3.2.2. The WW Domains 
The WW domain is a 35-40 amino acid protein-protein interaction module that 
was first identified as a repeat sequence in the YES-kinase-associated protein 
[194]. It was also identified by two independent groups, who named it the WWP 
[195] and Rsp5 domain [196]. In most cases, it contains two conserved tryptophan 
residues, hence the term WW domain [194], and conserved proline residue. Its 
structure consists of a three-stranded anti-parallel curved β-sheet, with the 
concave side forming a hydrophobic ligand-binding pocket [197]. WW domains are 
found in a large variety of proteins, and often in multiple copies. Some WW 
domain-containing proteins are implicated in diseases, including Alzheimer’s 
disease, muscular dystrophy and Liddle’s syndrome [198]. The PPxY sequence, 
known as the PY motif, was first identified in binding targets of the YES-kinase-
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associated protein [199] and constitutes the most common WW domain-binding 
motif, including those recognised by Nedd4-family protein WW domains. There 
have been reports of variations to the basic PY motif, in particular replacement of 
the first proline residue by leucine (LPxY) [200-202]. Evidence that Nedd4-family 
protein WW domains can interact with various phosphorylated ligands in addition 
to the PY motif greatly expands the number of potential binding targets. 
 
3.2.3. The HECT Domain 
The HECT domain was first identified in E6- AP. This led to the identification of 
other HECT-containing proteins including Nedd4 and Rsp5. The HECT domains of 
these proteins each contained a conserved cysteine residue responsible for 
thioester formation with ubiquitin [171]. It was subsequently found that the amino 
region of the Nedd4 HECT domain could mediate interactions with the E2 UbcH5b 
[203]. Nedd4 has also been shown to receive ubiquitin from other E2s, including 
UbcH5a, UbcH5c, UbcH6 and UbcH7 [203, 204]. Therefore, it can be expected 
that the HECT domain of Nedd4-family proteins is critical for substrate 
ubiquitylation, which can occur in the presence of a variety of E2s. However, it has 
been suggested that an additional, but ill-defined region of Nedd4 could also be 
important in determining E2 specificity [203]. The structure of the HECT domains 
from E6- AP and the Nedd4-family protein WWP1 have been determined [205, 
206]. They were found to be composed of two lobes; the amino lobe interacts with 
E2s and the carboxyl lobe contains the catalytic cysteine residue, separated by a 
flexible hinge [205, 206]. In addition to the catalytic cysteine residue that forms a 
thioester link with ubiquitin, it was recently shown that a conserved phenylalanine 
in the HECT domain is also required for functional E3 activity [207]. 
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3.3. Nedd4/Nedd4-like-mediated ENaC Regulation 
In 1996 Staub et al. [63] using a yeast two-hybrid screen, found that the 
carboxyl terminal of βENaC interacts with rat Nedd4, which like mouse Nedd4 has 
three WW domains. This interaction was prevented by introduction of PY motif 
point mutations, similar to those attributed to Liddle’s syndrome [63]. Since then 
many investigators have shown by various in vitro and in vivo approaches that 
ENaC PY motifs and Nedd4/Nedd4-like WW domains interact [14]. In particular, in 
vitro interaction of ENaC PY motif was shown with WW domains of Nedd4-1 [63, 
208-217], Nedd4-2 [114, 159, 217], WWP1 [218], and WWP2 [219]. These 
interactions with ENaC were confirmed in intact cells by co-immunoprecipitation 
with Nedd4-1 [63, 220] and Nedd4-2 [115, 220-222]. Subsequently, evidence has 
accumulated that the PY motifs of β οr γENaC interact with the WW domains 3 or 
4 of human Nedd4-1 or Nedd4-2 [211, 216, 217, 220, 223]. 
Several groups have demonstrated that ENaC is a protein with a rapid turnover 
of both the total and the cell surface pool (T1/2 = approx. 1 hour) [224-228]. Rapid 
turnover is a hallmark of ubiquitylated proteins; in the case of ENaC, this rapid 
turnover depends on both proteasomal and lysosomal degradation [227-229]. It 
has been shown using ENaC with cytoplasmic lysines mutated to arginine, hence 
with mutated putative ubiquitylation sites, that ubiquitylation of ENaC controls its 
cell surface expression but not its intrinsic activity (i.e., Po or single channel 
conductance [227]). So far there has been no direct demonstration that 
Nedd4/Nedd4-like proteins ubiquitylate ENaC. 
It has been demonstrated by several approaches that Nedd4/Nedd4-like 
proteins, in particular Nedd4, Nedd4-2, or WWP2, can regulate ENaC. In mouse 
mandibular cells, it is possible to interfere with Na+ feedback regulation by adding 
anti-Nedd4 antibodies or purified WW domains from Nedd4-1 or Nedd4-2 into the 
pipette of a whole-cell patch-clamp set-up and letting them diffuse into the cell [93, 
208, 210, 223]. Such data have been interpreted as evidence that either Nedd4 or 
Nedd4-2 is involved in Na+ feedback regulation in mandibular cells. Strong support 
for an involvement of Nedd4/Nedd4-like proteins in ENaC regulation comes from 
experiments done in the Xenopus laevis oocytes system, in which regulation of 
ENaC by co-expressed Nedd4-1 [94, 211, 215], WWP2 [219], and Nedd4-2 [220, 
221, 230] has been demonstrated. The strongest effects are seen with Nedd4-2. 
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Overexpression of Nedd4-2 leads to the nearly complete suppression of amiloride-
sensitive Na+ channels, an effect that is dependant on the PY motifs of ENaC 
[220, 221, 230]. Conversely, catalytically inactive Nedd4-2 mutants increase these 
currents, most likely by competing against endogenous Nedd4-2. Moreover, 
Nedd4-2 has been shown to control cell surface expression of ENaC [230]. 
 
3.4. The Tissue distribution of Nedd4 
Nedd4-2 expression is found in various tissues and cell types, suggesting that 
Nedd4-2 has multiple cellular functions [231]. Northern blot analysis revealed 
Nedd4-2 mRNA expression in brain, heart, lung, liver, and kidney [220, 221, 232]. 
Within the human kidney, Nedd4-2 mRNA was reported to be expressed along the 
entire nephron [233]. Loffing-Cueni et al. [231] confirm these data for the mouse 
nephron and extend them to the protein level by demonstrating localization of 
Nedd4-2 protein in several tubular portions. The highest expression levels of 
Nedd4-2 protein were seen in ASDN segments, consistent with the proposed 
regulatory role of Nedd4-2 for ENaC function. However, Nedd4-2 also was seen in 
tubular segments that do not express ENaC. In particular, PT cells showed a 
considerable amount of Nedd4-2 mRNA expression and protein immunostaining. 
 
3.5. The Deubiquitylating Enzyme Family (DUB) 
In addition to E1, E2s and E3s, ubiquitylation can be directly regulated by the 
effect of other proteins. A well characterised family of such proteins is that of the 
deubiquitylating enzymes (DUBs). On the basis of sequence comparison and 
enzymatic specificity, the DUB group can be divided into two families, the ubiquitin 
C-terminal hydrolases (UCH or UCH type-1) and the ubiquitin-specific processing 
proteases (UBP or UCH type-2). 
UCH enzymes are generally smaller in size (approx. 200 amino acids), are 
closely related in sequence, homologous to the cathepsin B cysteine proteases, 
are classified within the C12 peptidase family [234] and efficiently cleave small C-
terminal extensions and adducts from ubiquitin [235-237]. They specifically 
remove small peptides and proteins from the C-terminal Gly-76 of ubiquitin. Their 
function is to re-cycle ubiquitin monomers for ligation to new substrates. UCHs are 
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developmentally regulated and display tissue-specific expression [238, 239]. 
In contrast, UBPs range in size from 50 to 300 kDa and apart from the catalytic 
domains, UBPs can be extremely divergent, suggesting that they function in a 
substrate-specific manner [174, 240]. The UBP enzymes, classified within the C19 
peptidase family, are also involved in ubiquitin re-cycling, but their activity is 
directed towards the disassembly of various forms of polymeric ubiquitin or 
ubiquitin-like protein complexes [241]. 
UCHs are known to be required for processing ubiquitin-precursor proteins, 
whereas UBPs are purported to catalyze deconjugation of ubiquitin from larger 
protein substrates, and some members efficiently disassemble polyubiquitin 
chains [238, 242]. There is evidence for certain DUBs functioning to stabilize 
proteins by deubiquitylation, while DUB function is also attributed to ubiquitin 
cleavage from proteins during proteasomal degradation, resulting in the recycling 
of ubiquitin [174]. 
Nearly 20 DUBs have been identified in yeast, and the human genome is 
purported to contain more than 90 [172, 243]. The sheer number of DUBs 
contained in the genome suggests a potential for selective deconjugation of 
ubiquitin. Indeed, specific deubiquitylation of p53, a tumor suppressor protein 
whose expression is regulated by ubiquitylation, has been reported [244-246]. 
Also, type 2 iodothyronine deiodinase is specifically deubiquitylated by von Hippel-
Lindau protein-interacting deubiquitylating enzyme-1 [247]. Additionally, 
inactivation of individual DUBs produces distinct phenotypes; the Drosophila faf 
gene is required for normal eye development [248], mutations in CYLD predispose 
individuals for cylindromatosis [249], and cyk-3 mutants in Caenorhabditis elegans 
are defective in osmotic regulation and cytokinesis [250]. 
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3.5.1. The USP family 
Ubiquitin-specific proteases (USPs) are a large family of cysteine proteases, 
capable of cleaving both linear ubiquitin precursor proteins and posttranslationally 
formed ubiquitin–protein conjugates, and are the mammalian homologs of the 
yeast UBP family [251-253]. These enzymes contain two highly conserved 
sequence motifs that were discovered during sequence alignment of the first three 
yeast UBPs [251]. These are the “Cys box” and the “His box,” which contain a 
conserved cysteine and histidine residue, respectively, that were proposed to form 
part of the active site of these thiol proteases [251], consistent with the results of 
subsequent mutagenesis [248, 254-258] and structural [243] studies. The region 
between the Cys box and the His box defines the catalytic core responsible for 
deubiquitylating activity of the enzyme. USPs also contain N-terminal or/and C-
terminal extensions of varying length and unique sequence. The functions of these 
sequences remain poorly understood, although the extensions and insertions have 
been suggested to function in substrate recognition, subcellular localization of the 
enzymes, and protein-protein interactions. In addition to processing of Ub 
precursors and salvage of trapped Ubs, UBPs are responsible for removing Ub 
from polyubiquitylated proteins and for disassembly of free poly-Ub chains. Large 
family members of UBPs have been identified in a variety of organisms, which 
appear to regulate a diverse set of biological processes. 
Humans contain at least 28 USPs that have been characterized to varying 
extents [241, 252, 259], with a total of 50 suggested by analysis of the human 
genome sequence. The mouse genome would be expected to contain a similar 
number. It is proposed that the presence of such a large family of USPs in all 
eukaryotes is not required merely for the cleavage of ubiquitin precursors, and it is 
indicative of other regulatory roles in the ubiquitin pathway, where variable N-
terminal extensions might be responsible for specific functions in selecting and 
binding substrates, and/or mediating localization of the enzyme [240, 241, 259]. 
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4.  Na+ transport and Diseases 
 
4.1. Hyperaldosteronism 
In primary hyperaldosteronism aldosterone is produced in excess, e.g. due to 
an adenoma of aldosterone producing cells. In contrast, secondary 
hyperaldosteronism is the result of an increase in aldosterone secretion that is due 
to an external stimulus, e.g. renin overproduction. The symptoms of both 
conditions are similar: Hypernatremia (water loss exceeding sodium loss), 
hypokalemia (lowered potassium plasma levels) and alkalosis (lowered plasma 
proton concentration) leading to hypervolemia and hypertension. 
 
4.2. Pseudohypoaldosteronism 
Autosomal dominant and recessive forms of pseudohypoaldosteronism type 1 
(PHA1) are recognized. Patients suffering from this disease are resistant to the 
action of aldosterone but have markedly elevated plasma levels of aldosterone 
and renin. Major symptoms of PHA1 are hypotension (salt wasting) and 
hyperkalemia. The autosomal dominant form of PHA1 is characterized by a loss of 
the aldosterone effect due to mutations in the mineralocorticoid receptor gene 
[260, 261]. In contrast, the autosomal recessive form of PHA1 is caused by a “loss 
of function mutation” in any of the three subunits of ENaC. These mutations were 
originally described as truncations, frame shifts or missense mutations causing 
one amino acid substitution in the intracellular N-terminal region (α- and β-subunit) 
and in the extracellular loop (α- and γ-subunit) of the subunits. The missense 
mutation G37S in the N-terminal region of the β-subunit has been described to 
cause a dysfunctional channel postulating two basic mechanisms, defective 
protein trafficking and/or defective gating of the channel [262]. A second instructive 
missense mutation the C133Y in the extracellular loop of the α-subunit has been 
reported to lead to a reduction of Na+ transport caused by a less efficient transport 
of assembled Na+ channels to the plasma membrane [263]. 
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4.3. Liddle’s Syndrome 
Liddle’s syndrome is a rare autosomal dominant disorder elicited by mutations 
of β or γENaC subunit that result in a gain of function. The involved mutations were 
originally described as truncations or frame shifts in the C-termini of β or γENaC 
subunits [60, 264]. More detailed studies revealed, that these mutations delete a 
critical proline-rich region (PPxY-motif) of the C-terminal region of the protein that 
interacts with the protein ubiquitin ligase called Nedd4 [230]. A proposed 
mechanism is that the mutations prevent Nedd4 binding and thereby lead to a 
defective internalization of mutant ENaC [63]. This increases ENaC activity, as 
observed at the level of Xenopus laevis oocytes and Madin-Darby canine kidney 
cells [265, 266]. The symptoms of Liddle’s disease resemble primary 
hyperaldosteronism and severely suppressed plasma renin and plasma 
aldosterone levels. 
 
4.4. Gitelman’s and Bartter’s Syndrome 
Both diseases are caused by autosomal recessive mutations and produce 
distinctive clinical and physiological pictures of hypokalemic alkalosis. Molecular 
genetic approaches have demonstrated that mutations in the gene encoding the 
thiazide-sensitive Na+-Cl- cotransporter cause the Gitelman’s syndrome. Bartter’s 
syndrome appears to be a collection of several monogenic diseases. The cause is 
the lack of Na+ reabsorption in the TAL due to the dysfunction of either the apical 
bumetamide-sensitive Na+-K+-2Cl- cotransporter [267], the basolateral chloride 
channel [268, 269] or the apical potassium channel [270], which are all located in 
the TAL. 
The first three diseases described in this chapter concern the ASDN and thus 
indicate the importance of aldosterone regulated Na+ reabsorption in this part of 
the kidney tubule for the control of blood pressure. 
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 Materials and Methods 
 
 
Animal studies were in accordance with the Guide for Care and Use of 
Laboratory Animals (Institute of Laboratory Animal Resources, National Academy 
of Science, Bethesda, MD). 
 
1. Mouse Treatment, Kidney Dissection and Tubule Microcollection 
 
Female C57BL/6JOlaHsd mice (Harlan), approximately 8 weeks old, received 
drinking water containing 0.3% NaCl for at least 5 days prior to the treatment. All 
mice were housed in a temperature- and humidity controlled room with an 
automatic 12 h light/dark cycle (6 AM/ 6 PM). Aldosterone (Acrôs Organics) (10 
µg/kg body weight in 0.33% ethanol, 0.9% NaCl) or canrenoate (Sigma) (10 mg/kg 
in 0.9% NaCl) was injected intraperitoneally or mice left uninjected. Forty two 
minutes later, mice were anesthetized with ketamine (Vétoquinol AG) and xylasine 
(Streuli AG) (intraperitoneally 100 µg/g and 0.5 µg/g, respectively). They were then 
perfused through the left ventricle with Ringer solution containing collagenase and 
protease (5 mg and 1 mg in 15 ml, respectively) (Sigma) while the lower vena 
cava was opened. Kidneys were removed and cut transversally in 2 mm slices that 
were incubated for 10 min at 38°C in a collagenase solution (1 mg/ml Ringer 
solution). These tubule preparations were then transferred to ice-cold Ringer (1 h 
after aldosterone injection), washed and resuspended three times. Segments (75-
85) of CCD/CNT (approx. 1,1 mm of length) were identified under a binocular 
microscope (SMZ1000, Nikon) at 4°C and transferred directly into RLT lysis buffer 
of the Qiagen RNeasy Micro Kit (Qiagen) containing 1% β-mercaptoethanol 
(Sigma-Aldrich) using a pair of sharp forceps (F.S.T. GmbH). For plasma 
aldosterone and corticosterone measurements, mice were anesthetized as above 
and blood collected by puncture of the vena cava. Plasma aldosterone and 
corticosterone levels were measured using an ELISA- and a 125I-RIA-kit from IBL 
(Immuno-Biological Laboratories), respectively. 
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2. RNA Purification and Quality Control 
 
Total RNA from microcollected CCD/CNT was purified using RNeasy Micro Kit 
(Qiagen). The RNA samples were tested for quality using an Agilent 2100 
Bioanalyzer® (PicoChip®, Agilent Technologies) and for quantity using the ND-
1000 NanoDrop® UV-spectrophotometer (NanoDrop Technologies). Only samples 
showing a 28S/18S ribosomal RNA ratio ≥ 1 or a RNA Integrity Number (RIN; 
Agilent Technologies) >7 (range 1-10 with 10 for best RNA quality) were used for 
target cRNA preparation. 
 
3. Microarray Target cRNA Preparation 
 
RNA amplification and labeling was performed according to a two-cycle cDNA 
synthesis protocol.: 
Briefly, ≥ 30 ng of total RNA was 
concentrated to a volume of 
approximately 3 µl using a speed-vac 
system and used for first and second 
strand cDNA synthesis with the 
GeneChip® Two-Cycle cDNA Synthesis 
Kit (Affymetrix) in the presence of an 
oligo-dT primer containing a T7 RNA 
polymerase promoter site. cRNA was 
prepared by in vitro transcription using 
the MEGAscript T7 Kit (Ambion). The 
resulting cRNA was used for a second 
round of first-strand cDNA synthesis 
with random hexamer primers, followed 
by second strand cDNA synthesis with 
the same kit as above. Labeled target 
cRNA was then prepared in a second 
round of in vitro transcription using 
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biotin-labeled UTP (GeneChip® IVT Labeling Kit, Affymetrix). After each round of 
amplification the cRNA were tested for quality using an Agilent 2100 Bioanalyzer® 
(PicoChip®, Agilent Technologies) and for quantity using the ND-1000 NanoDrop® 
UV-spectrophotometer (NanoDrop Technologies). Only samples showing labeled 
cRNA average size distribution higher than 0.5 kb were accepted for hybridization. 
 
4. Target cRNA Hybridization and GeneChip® Scanning 
 
Biotin-labeled cRNA samples (15 µg) were fragmented randomly to 35-200bp 
at 94°C for 35 min in presence of Fragmentation Buffer (Affymetrix) and were 
mixed in 300 µl of hybridization buffer containing Eukaryotic hybridization control 
mix (Affymetrix) and Control Oligo B2 (Affymetrix), 0.1 mg/ml herring sperm DNA 
and 0.5 mg/ml acetylated bovine serum albumin in 2-(4-morpholino)-ethane 
sulfonic acid (MES) buffer, pH 6.7, before hybridization to GeneChip® MOE 430 
2.0 arrays. Hybridizations were carried out at 45°C for 16 h at constant rotation (60 
rpm). Subsequent washing and staining steps were performed using the Affymetrix 
Fluidics Station 450 EukGE-WS2v5_450 washing protocol (Affymetrix). Stained 
arrays were scanned using an Affymetrix® GeneChip® Scanner 3000 (Affymetrix), 
and the probe set intensity values for each gene were calculated by Affymetrix 
GeneChip® Operating System Software (GCOS 1.0, Affymetrix). 
 
5. Real-Time RT-PCR 
 
Samples of 3 µl RNA (out of 60 µl) were used as templates for reverse 
transcription using TaqMan® Reverse Transcription Kit (Applied Biosystems) in the 
presence of 2.5 µM random hexamer primers (Applied Biosystems). Real-time 
PCR was performed using 3.5 µl of the cDNA as template using the TaqMan® 
Universal PCR master mix (Applied Biosystems). Primers and probes were 
designed using Primer Express 2.0 software (Applied Biosystems) to result in 
amplicons of 70-100 bp that span intron-exon boundaries. Each primer pair (Table 
1.) was first tested on mouse kidney cDNA and resulted in a single product of the 
expected size (data not shown). Probes (Table 1.) were labelled with reporter dye 
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FAM at the 5’ end and the quencher dye TAMRA at the 3’ end (Microsynth). 
Reactions were run in 96-well optical reaction plates using a Prism 7700 cycler 
(Applied Biosystems). Thermal cycles were set at 95°C (10 minutes) and the 40 
cycles at 95°C (15 seconds) and 60°C (1 minute) with auto ramp time. 
 
Table 1. Primers and probes used for real-time RT-PCR 
gene sense primer (5’-3)’ probe (5’-3’) anti-sense primer (5’-3’) 
Grem2 Mm00501909_m1* 
Sgk1 GAG GGA GCG CTG CTT CCT 
ACC ACG GGC TCG 
ATT CTA CGC AGC 
GCA GAT AGC CCA 
GGG CAC T 
Atf3 AGA CCC CTG GAG ATG TCA GTC A 
CAA GTC TGA GGC 
GGC CCC TGA A 
CGC CTC CTT TTC 
CTC TCA TCT T 
Crem TTG GGA ATA CCA GGC ACA TCA 
AAA GTT CAT TCA 
GTA TTT TTC TAT ATG 
AGG GTC TTC GTG A 
TGA TTC GCA TAA 
ACG TAG AGA AAT 
TCT 
Usp2 TCT GTC CCC GTC CCT GC 
TGC TCA ACA AAG 
CCA AGA ATT CAA 
AGA GTG C 
AAG GTT TCG AAG 
ACC AGC CAG 
H+/K+-
ATPase Mm00446786_m1
* 
Slc22a8 TGC TTG GAT GGC TGG ATC TAC 
CAT TGT GAC AGA 
GTG GGA CTT GGT 
ATG CG 
TGC CAT CTC CTT 
CAG TTT GTT G 
G0s2 AAG TGC TGC CTC TCT TCC CAC 
CACA CCT AGG CCC 
AGC CAC CCA 
TTC CAT CTG AGC 
TCT GGG CT 
β-actin CCA CCG ATC CAC ACA GAG TAC TT 
AGG AGG AGC AAT 
GAT CTT GAT CTT 
CAT GG 
GAC AGG ATG CAG 
AAG GAG ATT ACT G 
αENaC GGT GCA CGG TCA GGA TGA G 
CTG CTT TTA TGG 
ATG ATG GTG GCT 
TCA A 
TAG TTG CCT CCG 
AGG CTG TC 
βENaC TCC TAG CTT GCC TGT TTG GAA 
AGA GCC CTG CAG 
TCA TCG GAA CTT CA 
CAG TTG CCA TAA 
TCA GGG TAG AAG AT
NKCC2 TCA CCA CCG TGG CCT ACA TA 
CTA TTT GCG TAG 
CCG CCT GTG TGG 
TC 
GGT GCA CGG TCA 
GGA TGA G 
*Applied Biosystems TaqMan® Gene Expression Assays ID 
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To analyze the data, the threshold was set to 0.06 (value in the linear range of 
amplification curves). All reactions were run in triplicates and the abundance of the 
target mRNAs was calculated relative to a reference mRNA (mouse β-actin). 
Assuming an efficiency value of 2 (fold-increase in input mRNA required to 
decrease the cycle number by 1), relative expression ratios were calculated as R = 
2(Ct(β-actin) – Ct(test)), where Ct is the cycle number at the threshold and test stands for 
the tested mRNAs. Based on this analysis, some samples (<1/3) were excluded 
from microarray target RNA synthesis because of high Na+/K+/2Cl--cotransporter 
(Nkcc2) contamination, a relatively low enrichment in α- and βENaC mRNA or, for 
aldosterone-treated mice, a Sgk1 upregulation <2-fold. Real-time RT-PCR was 
performed similarly for controlling the regulation of 8 mRNAs considered as highly 
regulated by microarray. 
 
6. Quality Control of Microarrays and Statistical Analysis 
 
Per condition, six GeneChips® were used for hybridization. Each hybridization 
was performed with target RNA from individual mice. Array images were inspected 
visually for artefacts and B2 Oligo performance. Raw data processing was 
performed using the Affymetrix Gene Chip Operating System Software (GCOS 
1.0, Affymetrix) and the GCRMA preprocessor of the Genespring software 7.1 
(Silicongenetics), respectively. Summarization for the respective probe sets giving 
rise to the actual expression values was carried out in two independent 
approaches using different algorithms; MAS5 and GCRMA. 
For the first approach the MAS5 algorithms was employed as detailed in Hubbell, 
E. et al. [271]). In order to compare the expression values of the genes from chip 
to chip, global scaling was performed, which resulted in the normalization of the 
trimmed mean of each chip to a target intensity (TGT value) of 500. The average 
background and noise (Raw Q) ranges from 40 to 100, and 1 to 5, respectively. 
Absent and present calls (>50%) were based on detection P-values calculated by 
application of a signed-rank call algorithm [272]. Optimal 3'/5' hybridization ratios 
(below 7) for the housekeeping genes (GAPDH and β-actin) and (around 1) for the 
spike-in controls (BIOB, BIOC, CREX, BIODN) added into the hybridization 
cocktail, were taken into consideration. The second algorithm applied for the probe 
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set summarization was the GeneChip Robust Multichip Average (GCRMA, [273]) 
as implemented in Genespring 7.1. GCRMA corrects for background noise, as well 
as non-specific binding. Quantile normalization was used to adjust the PM probe 
intensity distributions among all GeneChip measurements and summarization of 
the probe intensities into expression measures was carried out using a median 
polishing estimation method. 
To assess the significance of differential gene expression between the 
conditions tested, we applied statistical parametric methods based on the 
comparisons between the groups of replicates analyzed. Unreliable genes were 
filtered out using the absent/present calls resulting from the MAS5 analysis. 
Unequal variance t-test was applied to detect genes that were significantly 
differentially expressed with a significance level of P ≤ 0.05. Finally, the resulting 
significant genes were filtered for fold changes between the conditions of ≥ 2. 
 
7. Prediction of Mineralocorticoid Hormone Response Elements in 
the Promoter Region of the Mouse Usp2-45 Gene 
 
Consensus steroid hormone response elements contain symmetric imperfect 
direct, palindromic or inverted palindromic (everted) repeats of hexameric halfsite 
sequences such as 5’-AGAACA-3’ that are usually divided by 3 bp-long spacers. 
In order to predict potential binding sites for mineralocorticoid hormone response 
elements, we analyzed the promoter region -6.5 kb upstream of the ATG start 
codon of the mouse Usp2-45 gene by using the computational statistic models 
Position Weight Matrix (PWM) and Hidden-Markov-Model (HMM) implemented in 
the web-based program Tiger SHRE Finder 1.0 (http://birc.ntu.edu.sg/%7epmaria/ 
[274]. Within this region we found 13 HRE binding sites predicted by PWM 
(similarity coefficient bigger than 0.85) and 5 HRE by HMM (similarity coefficient 
bigger than 0.33). For better sensitivity, accuracy and avoiding false positive 
results both methods were taken together and 4 HRE sequences were predicted 
by both methods (Figure 17.). 
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8. Western Blotting of Usp2-45 in Microcollected Mouse Kidney 
Connecting Tubule and Collecting Duct 
 
Mouse treatment, kidney dissection and tubule microcollection were performed 
as described above for RNA preparation, but tubule segments (75-85) were 
transferred into RIPA buffer for lysis. Two µg total proteins were loaded per lane 
on a 10% SDS-polyacrylamide gel and subsequently transferred 
electrophoretically to a PVDF-membrane (Immobilon-P, Millipore). Blots were 
blocked and incubated with primary antibody as described below under “Western 
blot in mpkCCDc14 Cells” using 10 µg/ml anti-Usp2-45 antibody and monoclonal 
anti-β-actin antibody (1:5000, Sigma). In the peptide competition experiment the 
primary antibody was preincubated for 1 h at room temperature with the 
immunizing peptide at a 1:100 molar ratio (AB:peptide). The anti-Usp2-45 
antibody, blot incubation conditions and washes are described below in “Westen 
blot in mpkCCDc14 Cells”. The specific bands were quantified by using the AIDA 
Image Analyzer 3.44 program (raytest Inc.). 
 
9. Cloning of Mouse Usp2-45, Usp15, Site-Directed Mutagenesis and 
cRNA Preparation 
 
Mouse kidney or heart (Usp2-69) RNA was isolated with RNeasy Mini Kit 
according to the manufacturer’s protocol (Qiagen) and reverse transcribed 
(oligoDT primers) using the TaqMan Reverse Transcription Kit (Applied 
Biosystem). The Usp2-45 (RefSeq No NM_198091) and Usp15 (RefSeq No 
NM_027604) cDNAs were amplified by PCR using 2.5 U of a proofreading 
polymerase (Pfu, Promega), 1x Pfu-reaction buffer (Promega) 2mM dNTPs, 0.5µM 
5’-Primer, 0.5 µM 3’-Primer for 40 cycles (45 seconds 96°C, 1 minute 50-70°C, 5 
minutes 72°C). 
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The primers for PCR included restriction sites for cloning (each 5’XhoI, 
HindIII3’) and were ordered from Microsynth 
(Usp2-45: 5’-AAAACTCGAGCCGCGTTGGGTTTGGGGCATAG-3’, 
5’-AAAAAAGCTTGGGGCCACCACAGGGAAGAG-3’, 
     Usp15: 5’-AAAACTCGAGGCTAGTGGAAGAAGATGGCGGAAG-3’, 
5’-AAAAAAGCTTGGGATTTATTTGGGATTTCCT-3’, 
  Usp2-69: 5’-AAAACTCGAGCCCATGAGGCTCCCAGTACC-3’, 
5’-AAAAAAGCTTGGCCACCACAGGGAAGAGGGAAG-3’). 
The amplified PCR fragments were sub/cloned in the pSDeasy vector. Xenopus 
laevis ENaC subunit (αβγXENaC) and Xenopus laevis Sgk cDNAs (XSgk) were 
used [266, 275]. For changing cysteine 67 of Usp2-45 to alanine the 
QuickChange® site directed mutagenesis kit (Stratagene) was used with following 
primer pair: 
5’-AACCTTGGGAACACGGCTTTCATGAACTCAATT-3’; 
5’-AATTGAGTTCATGAAAGCCGTGTTCCCAAGGTT-3’. 
To generate the rENaC-Km mutant missing all potential ubiquitylation sites, all 
cytoplasmic lysines of rat α-, β-, or γENaC [58] were mutated to arginine using the 
Quickchange® kit (Stratagene). For cRNA synthesis, mUsp2-45, XSgk, βXENaC, 
αrENaC and βrENaC plasmids were linearized with BglII, α- and γXENaC with 
AflIII (Promega), γrENaC with PvuII and used as template for RNA synthesis with 
mMESSAGE mMACHINE™ kit (Ambion). 
 
10. Coexpression of mUsp2-45, mUsp15, αβγXENaC and XSgk in 
Xenopus laevis Oocytes 
 
Stage V and VI oocytes were injected with 10 to 36 ng of Usp2-45, Usp2-
45mut, Usp2-69, Usp15, 0.005 ng of each α-, β- and γXENaC subunit and 5 ng of 
XSgk cRNA in 100 nl of nuclease free water. Oocytes injected with αβγXENaC 
cRNA were incubated for 2 days at 16°C in ND10 buffer (10 mM NaCl, 2 mM KCl, 
1 mM MgCl2, 1.8 mM CaCl2, 86 mM N-methyl-D-glucamine (NMDG)-Cl and 5 mM 
HEPES, pH 7.4 adjusted with 1 M Tris, and 50 mg/l tetracycline), whereas oocytes 
not injected with XENaC cRNA were kept in ND96 buffer (NaCl instead of NMDG). 
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11. Two-Electrode Voltage Clamp on Xenopus Oocytes 
 
The two-electrode voltage clamp technique was used for the recording of 
whole-cell currents from Xenopus laevis oocytes at room temperature 40-48 h 
after injection with αβγXENaC, XSgk, mUsp15, mUsp2-69 and mUsp2-45 cRNA 
using a commercial two electrode voltage-clamp (Oocytes Clamp OC725C, 
Warner Instrument Corp.) connected to data acquisition hardware (Digidata 
11322A, Axon Instruments). A computer running pClamp8 software (Axon 
instruments) was used to control the clamp, the valves switching the solutions, and 
to record currents, as previously described [276]. For current-voltage (I-V) 
recordings, oocytes were clamped (Vh = -50 mV) and step changes in membrane 
holding potential were applied (-140 to +20 mV in 20 mV increments). At each 
membrane potential four pulses of 80 ms duration were averaged. Recordings 
were made in ND10 and ND96 solutions and 10 µM amiloride was added to the 
ND96 solution to obtain the amiloride-sensitive current. Calculations and graphs 
were made using GraphPad Prism™ Version 4.0 (GraphPad Inc.) and significance 
was tested using the Kruskal-Wallis or Mann-Whitney test if not stated otherwise. 
 
12. Ubiquitylation of ENaC in Hek293 Cells 
 
Hek293 cells, grown on 75 cm2 dishes were transfected by the calcium 
phosphate technique with 4.5 µg of the plasmids encoding rat ENaC subunits (HA-
tagged αENaC, βENaC [64], Flag-tagged γENaC [266]), 13.5 µg of Usp2-45 and 2 
µg of hNedd4-2 (wild-type or inactive mutant; as indicated [277]). After 24 hours, 
cells were washed with 10 ml of PBS and dissociated in 1 ml of dissociation buffer 
(5% glycerol, 1 mM EDTA, and 1 mM EGTA, pH 8.0). Cells were recovered with 
10 ml PBS, centrifuged for 2 min at 4°C and 1500 g and pellets frozen at -70 °C. 
Cells were lysed in 1 ml buffer containing 50 mM HEPES, pH 8.0, 150 mM NaCl, 1 
mM EGTA, 10 % glycerol, 1 % Triton X-100, 1 mM dithiothreitol, 100 mM NaF, 10 
mM di-Na-pyrophosphate, 1 mM PMSF, 1 x protease cocktail (Roche) and then 
centrifuged for 15 minutes at 21’500g (4°C). Supernatants were recovered and 
immunoprecipitations carried out with anti-HA antibodies (recognizing HA-tagged 
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αrENaC; Santa Cruz) or anti Flag antibodies (recognizing flag-tagged γrENaC; M2, 
Sigma) for 2.5 h. Immunocomplexes were recovered with protein G sepharose 
during 1.25 h at 4°C on a rotating wheel. Protein G sepharose was washed with 
washing buffer (50 mM HEPES, pH 8.0, 150 mM NaCl, 1 mM EGTA, 10 % 
glycerol, 0.2 % Triton X-100, 1.5 mM MgCl2, and 1 mM PMSF) and the immune 
complexes recovered in SDS-PAGE sample buffer. The samples were analyzed 
on 8 % or 5-15 % SDS-PAGE and Western blotting using anti αrENaC, γrENaC 
antibodies [227], or anti-ubiquitin antibodies (FK2, Affinity). 
 
13. Culture and Retroviral Transduction of mpkCCDc14 Cells 
 
The mouse kidney cell line mpkCCDcl4 and its culture was originally described 
by Bens et al. [278]. For electrophysiological and RNA expression measurements, 
mpkCCDcl4 cells were seeded respectively on 12 mm diameter Snapwell filters or 
24 mm diameter 24-well plastic plates (Corning Costar). After 5–7 days of culture 
in standard medium and for electrophysiology an additional 2-7 days in filter 
medium (growth medium without serum, Apo-transferrine and EGF) cells were 
transferred into serum- and hormone-deprived medium 12 – 20 h prior to the 
experiments [279]. Because of the lack of sufficient mineralocorticoid receptor 
expression in mpkCCDc14 cells, aldosterone was used at 0.3 or 1.0 x 10-6 M to 
obtain near-maximal effects via the glucocorticoid receptor [279]. 
Stable populations of mpkCCDc14 cells expressing Usp2-45, and Usp-2-45mut 
were obtained according to the protocol provided on the website 
http://www.stanford.edu/group/nolan/ with slight modifications [280]. Briefly, 
ecotropic pseudoretroviral producer cells (Phoenix) were plated 24 h prior to 
transfection at 50% density on 60 mm plates. The next day, 5 µg of the retroviral 
construct encoding Usp2-45 or Usp2-mut were applied using FuGENE6 (Roche) 
according to the manufacturers recommendation. The medium was replaced after 
24 h and the cells subsequently kept at 32°C. The pseudoretrovirus-containing 
supernatant was harvested after 24 h and filtered through a 45 µm sterile filter. 
After addition of Polybrene at a final concentration of 4 µM, the entire supernatant 
(3 ml) was given to 5% confluent mpkCCDcl4 cells plated the day before on 6-well 
plates (35 mm diameter). The cells were centrifuged at 130 g and 32°C for 30 min 
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and then kept for 6 h at 32°C (5% CO2) before the supernatant was replaced by 
usual medium. The procedure was repeated the next day using fresh retroviral 
supernatant harvested from the same Phoenix cells. A transduction efficiency of 
70–100% was achieved when using EGFP (enhanced green fluorescent protein) 
as a marker. This protocol was repeated 2 times to achieve maximal expression. 
The resulting multiclonal cell populations were then kept under selective pressure 
with 1 µg ml−1 puromycin. 
 
14. Western Blotting and Real-Time PCR of Usp2-45 in mpkCCDc14 
Cells 
 
An antibody selective for the Usp2-45 isoform of mouse Usp2 was raised 
against a NH2-terminal epitope (MRTSYTVTLPEEPAAC) (Pineda) and affinity 
purified on antigen peptide using the SulfoLink® Kit (Pierce/Perbio) according to 
the manufacturer protocol. The antibody against both, Usp2-45 and Usp2-69 was 
ordered from Abgent (Cat.Nr.:AP2131c) mpkCCDc14 cells were harvested from 
plastic cultures and lysed in RIPA buffer (150mM NaCl, 1% IPGAL, 0.5%DOC, 
0.1% SDS, 50mM Tris, pH7.5) by passing them 10 times through a 25 G needle 
and Xenopus oocytes were lysed in buffer (10 µl per oocyte) containing 250 mM 
sucrose, 0.5 mM EDTA, 5 mM Tris-HCl, pH 6.9, 1 mM PMSF, and 1 mg/ml of 
leupept also by passing them 10 times through a 25 G needle. Oocyte debris were 
pelleted by two consecutive centrifugations at 100 g for 10 min. Equal amounts of 
proteins derived from mpkCCDc14 cells and a smaller amount from oocyte 
expressing Usp2-45, Usp2-69 and/or ENaC were loaded on a 10% SDS PAGE 
and subsequently transferred electrophoretically to a PVDF-membrane 
(Immobilon-P, Millipore). After blocking with 3-5% milk in Tris-buffered saline/ 
0.1% Triton X-100 (Sigma-Aldrich) overnight at 4°C or 2 h at room temperature, 
the blots were incubated with primary antibody (10 µg/ml anti-Usp2-45) for 2 h at 
room temperature or overnight at 4°C. After washing and subsequent blocking for 
1 h at room temperature, blots were incubated with goat anti-rabbit secondary 
antibody conjugated with horseradish peroxidase (1:10,000; BD Transduction 
Laboratories) for 1 h at room temperature. Antibody binding was detected with the 
Super-Signal1 West Pico Substrate (Pierce). Chemiluminescence was detected 
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with a DIANA III camera (Raytest). RNA extraction and TaqMan® real time RT 
PCR were performed as indicated for mouse kidney and tubules. The Usp2 
isoform-specific primers and probes are indicated in Table 1. 
 
15. Transepithelial Electrophysiological Measurements 
 
A transepithelial resistance of 2 kOhm x cm2 was considered as prerequisite for 
using the filter cultures for further electrophysiological measurements. Filters were 
mounted in a multichannel voltage current clamp device (Model VCC MC6 
Revision B, Physiological Instruments) and monolayers maintained under current 
clamp conditions at a DC clamp level of 0 µA. Bipolar pulses of 5 µA were given 
for 620 ms every 60 sec. After 90 min, aldosterone (300 nM) was added to the 
medium. The ENaC-mediated sodium current was specifically blocked by 10 µM 
amiloride after another 150 min and calculated as the difference in short circuit 
current before and 15 min after amiloride addition. 
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 Results 
 
 
Beforehand presenting the results of this study I would like to note the contribution 
to this work by Gabriele Adam for the Xenopus oocytes and Olivier Staub and 
collegues for the Hek293 cells expression studies. 
The results presented in this following section have been published in the    
Journal of American Society of Nephrology (JASN) in March 2007. 
 
 
 
(J Am Soc Nephrol 18: 1084–1092, 2007) 
* both authors contributed equally to this work 
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1. Microarray to Identify Early Aldosterone-Regulated mRNAs in 
Mouse ASDN 
 
To identify other early aldosterone-regulated gene products in kidney target cells 
in vivo, we first established a short-term aldosterone treatment scheme in mice. 
Female C57BL/6J mice receiving 0.3% NaCl in their water to partially repress their 
endogenous aldosterone production were injected at 10:00 AM (4 hours after 
begin of daytime) with aldosterone (10 µg/kg body weight, Figure 14.A and B), or 
not injected. 
 
Figure 14. Conditions of short-term aldosterone stimulation. (A) Time-course of plasma 
aldosterone and corticosterone levels after intraperitoneal aldosterone injection (10 µg/ kg body 
weight) at 10 AM (mean ± SEM, n = 3 mice per time point). (B) Comparison of plasma aldosterone 
(aldo) and corticosterone (cort) at 10 AM and at 10.30 with or without (non) injection of vehicle at 
10 AM (mean ± SEM, n = 3 - 6 mice per point). 
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The aldosterone injection led to a transient increase in plasma aldosterone which 
15 min after injection was at a level of ~10 nM, a value within the range expected 
in low salt diet [281]. The plasma aldosterone concentration was nearly back to the 
initial value of approximately 0.5 nM after 60 min. 
To obtain kidney aldosterone-target tissue RNA 1 h after hormone injection, mice 
were anesthetized 42 min after aldosterone injection and rapidly perfused with 
collagenase solution. Kidneys were removed, sliced and further digested in 
collagenase solution at 38°C for the rest of the hour (in the absence of 
aldosterone). The tubule preparation was then transferred to 4°C and segments of 
connecting tubule and cortical collecting duct (CNT/CCD) microselected. 
The RNA samples prepared from single mice were tested in terms of quantity, 
integrity, enrichment, contamination and response to aldosterone (Figure 15.C and 
D). 
 
Figure 15. (C) and (D) Test for enrichment and aldosterone stimulation of RNA prepared from 
microselected CNT/CCD. Mice were injected with aldosterone as in (A), canrenoate or not injected 
and RNA prepared from tubules obtained after 1 h. The abundance of α-, βENaC, Sgk1 and Nkcc2 
mRNAs was measured by real-time RT-PCR in RNA prepared from total kidney (C) and from 
microselected tubule segments (D). Given are means relative to β-actin ± SEM, n = 6 mice. 
***P<0.0001 by 1 way-ANOVA. 
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These measurements revealed that in microisolated CNT/CCD segments ENaC 
mRNA was enriched 15 - 40-fold over total kidney, whereas thick-ascending limb-
specific triple cotransporter Nkcc2 mRNA was not increased. Sgk1 mRNA was 
enriched 3 - 4-fold over the total kidney preparation and specifically further 
increased 5 - 6-fold by aldosterone. Interestingly, the mere manipulation of the 
mice increased plasma corticosterone slightly (Figure 14.A and B) but did not 
impact on Sgk1 expression (Figure 15.C and D). More than two third of the 
prepared RNA samples fulfilled the selection criteria of quantity, integrity, 
enrichment, lack of contamination and SGK1 induction and could be used as 
template for cDNA amplification and labelled target RNA synthesis. Target cRNAs 
made from 6 control and from 6 aldosterone-injected mice were separately 
hybridized to mouse full genome GeneChip® microarrays (MOE 430 v2, 
Affymetrix). Raw array data were processed using the GCRMA and the MAS5 
algorithms (Microarray data are available at Array Express with the accession 
number E-TABM-229.). The data were filtered using a t-test with a cut-off P-value 
of P ≤ 0.05 and using a fold-change limit of 2.0. The cumulative list of genes that 
fulfilled these criteria after processing with one of the algorithms comprised 90 
genes (73 genes with GCRMA and 39 with MAS5). A scatter plot and the 
hierarchical clustering of the results calculated by the GCRMA method are shown 
in Figure 16.. 
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Figure 16. Scatter plot and hierarchical clustering of aldosterone-regulated mRNA. (A) Scatter plot 
calculated by the GCRMA method. The left panel shows the expression values (GCRMA values) of 
the 90 gene products of the cumulative list (2-fold regulation, P<0.05, with GCRMA or MAS5 
algorithm). The right panel shows the 22 genes that fulfill the selection criteria for both methods. 
The expression values range within more than two orders of magnitude and the absolute highest 
signal is that of the Sgk1 mRNA. (B) Hierarchical clustering of the tested mice based on the 
cumulative list of genes. This graphical view of the GCRMA data visualizes the individual variability 
of expression of some mRNAs in particular in the non-treated mice. 
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As detailed in Table 2, 22 genes fulfilled these criteria with both algorithms, 9 that 
are upregulated and 13 downregulated. We retested the differential expression 
level of 8 mRNAs identified in the microarray screen by real-time PCR (see 
primers and probes sequences in Materials and Methods) on RNA from three 
other mice per condition. As shown in Table 2, the regulation was verified in 6 
cases. 
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Table 2. Kidney CNT/CCD RNAs changed ≥ 2-fold by 1 h aldosterone 
 
                                                                                                 Affymetrix® 
GeneChip 
real-time PCR 
RNA* Genebank 
Acc. No. 
fold 
change
‡ 
range P-value fold 
change
§ 
P-value
Upregulated genes 
protein related to DAN and cerberus† NM_011825 7.2 2.1 - 17.7 0.045 5.6 0.029 
serum/glucocorticoid regulated 
kinase NM_011361 4.0 3.0 - 5.1 3.4E-05 8.1 0.001 
activating transcription factor 3 BC019946 3.5 2.5 - 4.9 0.001 8.6 0.018 
cAMP responsive element modulator NM_013498 3.0 1.3 - 4.5 0.004 1.1 0.651 
Mus musculus transcribed 
sequences AI098139 2.9 1.7 - 3.6 1.4E-04   
RIKEN cDNA clone:6430570G24 BG069663 2.8 1.7 - 4.4 0.004   
ubiquitin specific protease 2 AI553394 2.2 1.2 - 3.8 0.019 1.6 0.001 
growth arrest and DNA-damage-
inducible 45 gamma AK007410 2.2 1.5 - 3.2 0.001   
RIKEN cDNA clone:6430570G24 BG069663 2.2 1.5 - 2.9 8.7E-05   
Downregulated genes 
RIKEN cDNA 4833417L20 gene AK017914 0.5 0.3 - 0.9 0.014   
Similarity to pir:A45973 (H.sapiens) AI597080 0.5 0.3 - 0.6 0.009   
argininosuccinate synthetase 1 BM213298 0.4 0.3 - 0.5 0.007   
RIKEN cDNA clone:D630044A17 BB498095 0.4 0.2 - 0.6 0.006   
partial mRNA for hypothetical prot. BG817292 0.4 0.3 - 0.6 0.006   
fatty acid binding protein 1, liver NM_017399 0.4 0.2 - 0.8 0.006   
transcribed  sequences BE991175 0.4 0.2 - 0.6 0.006   
RIKEN cDNA clone:C230084M03 BM123508 0.4 0.2 - 0.8 0.005   
RIKEN cDNA 4833417L20 gene BM217861 0.4 0.3 - 0.4 0.004   
H+/K+-ATPase alpha, nongastric NM_138652 0.4 0.1 - 0.8 0.004 1.0 0.946 
Slc22a8 (Oat3) AV330315 0.3 0.1 - 0.6 0.004 0.1 0.024 
G0/G1 switch gene 2 NM_008059 0.3 0.2 - 0.6 0.003 0.2 0.015 
RIKEN cDNA clone E030031K24 BB533736 0.3 0.2 - 0.5 0.003   
 
*RNAs with fold-change ≥ 2 and t-test P-value P ≤ 0.05 using GCRMA and MAS5 algorithms 
†RNAs indicated in italic were also tested by real-time RT-PCR 
‡Values obtained using GCRMA 
§Real-time PCR data obtained with specific intron spanning primer/probe sets, n = 3 mice 
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2. Aldosterone-Induced Usp2-45 Deubiquitylates ENaC 
 
Ubiquitylation of ENaC had previously been shown to play an important role for the 
control of Na+ reabsorption [115] and the present screening had confirmed that 
Sgk1, a kinase known to inhibit the action of the ubiquitin-protein ligase Nedd4-2 
on ENaC, was rapidly induced by aldosterone. We focussed now on Usp2, an 
ubiquitin-specific protease that was also induced and belongs to a large protein 
family involved in reversing the ubiquitylation of target proteins [240, 282, 283]. We 
specifically investigated the potential role of the isoform Usp2-45 that we detected 
in kidney by RT-PCR, unlike the other isoform Usp2-69 that is expressed only at 
low levels in the kidney [284] (Fakitsas and Verrey, unpublished observation) and 
in mpkCCDc14 cell (10-fold difference, see below). The analysis of the promoter 
region around the TATA box of the Usp2-45 isoform identified at least 4 potential 
hormone response elements that support the possibility of a direct regulation by 
aldosterone (see Figure 17.). 
 
 
Figure 17. Predicted hormone response elements located in the promoter region of the mouse 
Usp2 gene. The HRE’s predicted only by using the computational statistic models Position Weight 
Matrix (PWM) are indicated as red segments and the ones predicted by both PWM and the Hidden-
Markov-Model (HMM) are indicated as blue segments [274]. 
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An induction by aldosterone of the shorter Usp2-45 isoform, but not of the Usp2-69 
isoform, was also detected in mpkCCDcells (see below). 
To test whether the aldosterone-induced Usp2-45 mRNA induction translates in 
vivo into an increase in Usp2-45 protein, we performed Western blotting of 
proteins prepared from microselected segments of connecting tubule and cortical 
collecting duct (CNT/CCD) obtained from mice subjected to the same hormonal 
treatment as previously performed for the mRNA studies. 
 
 
Figure 18. Usp2-45 detected by Western blot in connecting tubule and cortical collecting duct 
(CNT/CCD). Aldosterone treatment and tubule microselection were as described for mRNA 
preparations. (A) Western blot with rabbit anti-mouse Usp2-45 antibody ± immunizing peptide 
identifies a 45 kD band that is competed by immunizing peptide. (B) Representative pair of 
Western blots from a control and an aldosterone treated mouse. The upper panels show the actin 
band and the lower panels the Usp2-45 band visualized on the same blots. (C) The Usp2-45 
signals were normalized to the actin signal of the same animal (n = 3 for each condition) and the 
means are shown. **P<0.01. 
 
As shown in Figure 18., the polyclonal rabbit anti-mouse Usp2-45 antibody 
recognized a 45 kD band that was blocked by competing immunizing peptide. This 
band was selectively increased 1 hour after an aldosterone injection by a factor of 
approximately 2, as previously shown for the mRNA. 
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The fact that the Usp2-45 mRNA indeed encodes an active ubiquitin-specific 
protease was confirmed by the fact that its core domain produced in E. coli very 
efficiently cleaves ubiquitin off from a test substrate in vitro (Oberfeld, Verrey and 
Pos, unpublished results and [285]). 
To test the possible impact of Usp2-45 on ENaC function, we co-expressed it with 
ENaC in Xenopus laevis oocytes and compared the effect of Usp2-45 to that of 
Sgk1, the kinase that inhibits endogenous Nedd4-2. Co-expression of Usp2-45 
with ENaC increased the level of amiloride-sensitive Na+ current nearly 4-fold, an 
effect similar to that of Sgk1 (Figure 19.A, Figure 20.A and B). Interestingly, co-
expression of Sgk1 with Usp2-45 did not further increase ENaC function, 
suggesting that these two enzymes have an impact on the same regulatory 
mechanism (Figure 19.A and Figure 20.B). 
To test whether the effect of Usp2-45 was mediated by its protease activity, we 
mutated its cysteine 67 that corresponds to one of the catalytically active amino 
acids of its cysteine protease motif [284, 286]. Consistent with a requirement for 
an enzymatically active Usp2-45, this mutant did not affect ENaC activity at the 
membrane (Figure 19.B and Figure 20.C). To control whether this effect of Usp2-
45 was specific for this ubiquitin-specific protease, we carried out the same 
experiment with another randomly chosen ubiquitin-specific protease, Usp15. The 
results indicated that the effect of Usp2-45 is specific, since co-expression of 
Usp15 in contrast rather decreased ENaC function (Figure 19.C and Figure 20.D). 
It is probable that this latter effect is due to the deubiquitylation of other proteins 
that interfere with the expression of ENaC. 
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Figure 19. Usp2-45 increases amiloride-sensitive Na+ current (Iamil) carried by coexpressed 
αβγENaC. Original tracings are shown in Figure 20. of the Supporting Material. (A) Summary of 
amiloride-sensitive whole-cell currents at a holding potential of -100 mV. Coexpression of Usp2-45 
or of XSgk1 increased the ENaC-mediated amiloride-sensitive Iamil to a similar extent. These effects 
were not additive. Means ± SEM, n = 23 - 27. **P<0.01, ***P<0.001. (B), (C) and (D) 
Characterization of Usp2-45 stimulatory effect on Iamil in Xenopus oocytes. (B) Cys67Ala protease 
dead Usp2-45 mutant (Usp2-45mut) does not stimulate XENaC current, Iamil at -100 mV. Means ± 
SEM, n = 12 - 15. **P<0.01. (C) Another Usp (Usp15) does not stimulate XENaC-mediated Iamil at -
100 mV. Means ± SEM, n = 20 - 24, *P<0.05, ***P<0.001. (D) The Usp2-69 isoform does not 
stimulate XENaC-mediated Iamil at -100 mV. Means ± SEM, n = 20 - 22. ***P<0.001.  (E) Western 
blot made with lysate of control- and Usp2-45 and Usp2-69 expressing Xenopus oocytes and 
incubated with a pan-Usp2 antibody shows specific bands corresponding to each isoform, 
confirming that both were similarly expressed and that the lack of ENaC stimulation by Usp2-69 
was not due to a lack of expression of this isoform. (F) Effect of Usp2-45 on ENaC-mediated Iamil is 
prevented by mutation of rENaC PY motif (rENaC-PYm). Iamil at -100 mV is shown. Means ± SEM, n 
= 4 independent experiments with a total of 20 oocytes, *P<0.05 using paired t-test. (G) Effect of 
Usp2-45 on ENaC-mediated Iamil is prevented by mutation of rENaC ubiquitylation site (lysine-
mutant rENaC-Km). Iamil at -100 mV is shown. Means ± SEM, n = 4 - 5 independent experiments 
with a total of 20 and 25 oocytes, respectively, *P<0.05, **P<0.01, ***P<0.001. 
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Figure 20. Usp2-45 increases Iamil carried by coexpressed αβγXENaC. (A) Typical recordings of 
XENaC-mediated amiloride-sensitive Na+ current (Iamil) with or without coexpression of XSgk1 
and/or Usp2-45 in Xenopus laevis oocytes clamped at -50 mV. Bath sodium concentrations and the 
presence of 10 µM amiloride are indicated. Switching from 10 to 96 mM Na+ increased inward 
current that was blocked with 10 µM amiloride. (B) Current-voltage (I-V) relationships of the 
amiloride-sensitive current (n = 23 - 27 oocytes from 4 - 5 batches). (C) and (D) Characterization of 
Usp2-45 stimulatory effect on Iamil in Xenopus oocytes. (C) Cys67Ala protease dead Usp2-45 
mutant (Usp2-45mut) does not stimulate XENaC current, current-voltage (I-V) relationship (n = 12 
– 15). (D) Another Usp (Usp15) does not stimulate XENaC-mediated Iamil. Current-voltage (I-V) 
relationship, (n = 20 – 24). 
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Additionally, we also coexpressed the longer Usp2-69 isoform that turned out not 
to impact onto ENaC function (Figure 19.D). In this case, we also verified by 
Western blotting that this ubiquitin-specific protease isoform was indeed 
expressed as expected (Figure 19.E). 
We then asked whether Usp2-45 interferes with Nedd4-2-dependant regulation of 
ENaC, a mechanism that involves the interaction of Nedd4-2 with PY-motifs 
present on the C-termini of the ENaC subunits and is defective in Liddle’s 
syndrome [230]. ENaC devoid of PY-motifs (alpha Y673A, beta Y618H, gamma 
Y628A) is resistant to Nedd4-2 and thus displayed a higher level of amiloride-
sensitive Na+ current than wild type ENaC. This current was indeed resistant to the 
stimulatory action of Usp2-45 (Figure 19.F). This observation supports the 
hypothesis that Usp2-45 cleaves off ubiquitin moieties that Nedd4-2 ligates onto 
ENaC (see scheme in Figure 24.). The involvement of direct ENaC ubiquitylation 
was then verified by coexpressing Usp2-45 with ENaC devoid of potential 
ubiquitylation sites (lysine residues of the intracellular NH2-terminal domains of all 
three subunits mutated to arginine) in Xenopus oocytes. As expected for the case 
that Usp2-45 deubiquitylates ENaC directly, this mutant channel was not activated 
in the presence of Usp2-45 (Figure 19.G). 
To verify that the effect of Usp2-45 on ENaC function was not an artefact due to 
the coexpression of two proteins in Xenopus oocytes but also takes place with 
endogenous ENaC in CCD cells, we addressed this question using the mouse 
cortical collecting duct cell line mpkCCDc14 [278]. We actually first verified whether 
Usp2-45 is expressed and regulated by aldosterone in these cells. The relative 
expression of the two isoforms in mpkCCDc14 cells was similar to the observation 
made in microdissected CNT/CCD with a 10-fold higher expression of the Usp2-45 
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mRNA. The time course of the regulation by aldosterone revealed that only the 
Usp2-45 isoform was regulated (Figure 21.A). 
 
 
Figure 21. Expression of endogenous and exogenous Usp2-45 in mpkCCDcl4 cells. (A) Regulation 
of endogenous Usp2-45, Usp2-69 and Sgk1 mRNAs by aldosterone (10-6 M, see Methods in 
Supporting Materials and [279]) in mpkCCDc14 cells. Usp2-45 upregulation is slightly more delayed 
than that of Sgk1. Unlike its isoform Usp2-45, Usp2-69 is not induced by aldosterone. Baseline 
mRNA abundance of Usp2-45 was 10-fold higher than that of Usp2-69. Fold changes of 
normalized means relative to β-actin ± SEM are given, n = 3. The isoform-specific Taqman® real 
time PCR primers and probes are shown in supporting information. (B) Baseline transepithelial Iamil 
across mpkCCDcl4 cell monolayers cultured on permeable supports is significantly increased in 
cells overexpressing Usp2-45 compared to vector-transduced negative control cells (NC) and cells 
transduced with protease-dead Usp2-45mut (open bars) (*P < 0.05, n = 9-12). Aldosterone (300 
nM) given for 3 hours increased Iamil similarly in the monolayers made of the different mpkCCDcl4 
cell populations (grey bars). 
 
 
 
 
 
 
 
 
Results  79 
To investigate the effect of Usp2-45 on the transepithelial Na+ transport function, 
we expressed exogenous Usp2-45 as well as mutant protease-dead Usp2-45 in 
mpkCCD cells by retroviral transduction and verified by Western blot that the 
expression levels were equal (Figure 22.). 
 
 
 
 
 
 
Figure 22. Expression of endogenous and exogenous Usp2-45 in mpkCCDcl4 cells. Western 
blotting of Usp2-45 in mpkCCDc14 cells. In transduced mpkCCDc14 cells, Usp2-45 wild type (lane 2) 
and protease dead mutant (lane 3) appear as ~41 kDa bands (arrow head) of similar intensity. 
Endogenous Usp2-45 is not clearly visible in wild type and vector-transduced mpkCCDcl4 cells 
(lane 4 and 5). Lane 1 shows Usp2-45 expressed in Xenopus laevis oocytes. The band at ~36 kDa 
in lane 2 - 5 (mpkCCDc14 lysate) is unspecific. 
 
As expected if ENaC expression and activity was limited by its ubiquitylation, 
expression of functional Usp2-45 increased the baseline transepithelial amiloride-
sensitive Na+ transport (Figure 21.B). In contrast, the expression of the protease-
dead mutant had no effect. The increase in Na+ transport induced by aldosterone 
(300 nM, see Materials and Methods and [279]) given for three hours was not 
modified significantly by the expression of wild type and mutant Usp2-45, as 
expected considering that short-term aldosterone prevents the Nedd4-2-mediated 
ubiquitylation of ENaC by inducing SGK1. These results obtained in CCD cells 
confirm that Usp2-45, an ubiquitin-specific protease identified because of its in 
vivo regulation by aldosterone, also acts on endogenous ENaC in kidney tubule 
cells. 
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To directly test the hypothesis that Usp2-45 counteracts the effect of Nedd4-2 by 
deubiquitylating ENaC, we used Hek293 cells as expression system. 
 
Figure 23. Inverse regulation of ENaC ubiquitylation and ENaC amount. (A) The ubiquitylated and 
the total amount of ENaC expressed in Hek293 cells are visualized by Western blotting (IB) of 
immunoprecipitated (IP) HA- and Flag-tagged α- and γrENaC subunits, respectively. The MW of 
marker proteins is indicated in kDa. Co-expression of Nedd4-2, and not of ligase-inactive Nedd4-2 
(Nedd4-2cs), increases the ubiquitylation of both tested ENaC subunits, whereas it decreases their 
total amount. In the presence of Usp2-45, ENaC ubiquitylation is decreased and the total subunit 
amount increased. 
 
Coexpression of Nedd4-2 with ENaC in Hek293 cells massively increased the 
ubiquitylated form of the channel that was visualized with anti-ubiquitin antibody on 
immunoprecipitates of α- and γ−ENaC, thus confirming that ENaC was itself 
ubiquitylated (Figure 23.A). The impact of ubiquitylation on the total amount of 
ENaC was demonstrated by the decreased amount of ENaC visualized in the 
same samples with anti-ENaC antibody. Importantly, Usp2-45 co-expression 
decreased the amount of ubiquitylated ENaC and increased total ENaC, 
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demonstrating that Usp2-45 antagonizes the effect of Nedd4-2 by directly 
deubiquitylating ENaC. 
The low level of ubiquitylated ENaC and the substantial level of total ENaC 
observed with Usp2-45 co-expression were similar to those observed with Nedd4-
2cs, a catalytically inactive Nedd4-2 (Figure 23.A). 
 
Discussion  82 
 Discussion 
 
1. Early Aldosterone-Regulated Gene Products 
 
The number of mRNAs the level of which was changed ≥ 2-fold in mouse ASDN 
within one hour after an aldosterone injection is relatively low (22 mRNAs). It is 
noteworthy that the signal intensity of these regulated mRNAs on control mice 
arrays differs by more than two orders of magnitude indicating large differences in 
their absolute baseline expression levels (see Figure 16.A). Not unexpectedly, the 
gene product with the highest absolute expression level and the second highest 
relative level of induction is Sgk1, the only early aldosterone-regulated gene 
product of mammalian kidney that has been identified earlier and shown to 
activate ENaC. 
The gene product with the highest fractional increase (7.2-fold in Affymetrix 
screen, 5.6-fold by real-time RT-PCR) is Grem2 (PRDC), an antagonist of bone 
morphogenic proteins (BMP) 2, 4, 6 and 7 [287]. BMP’s are the largest group 
within the TGFβ superfamily and regulate gene transcription via heteromeric BMP 
receptors and Smad pathways [288, 289]. Thus aldosterone-induced Grem2 might 
support cellular differentiation by preventing BMP-mediated transcriptional 
activation of genes as for instance that of the inhibitor of differentiation 1 (Id1) 
[290]. 
The second upregulated gene product on the list is the already mentioned Sgk1 
that is followed by two members of the CREB family of transcription factors, 
activating transcription factor 3 (Atf3) and cAMP responsive element modulator 
(Crem). Atf3 is actually a transcription inhibitor that is known to be induced by 
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stress and to exert its inhibitory function on certain promoters in cooperation with 
Smad3. Such an inhibitory effect has been demonstrated in epithelial cell lines on 
the gene of Id1, the inhibitor of differentiation mentioned above as a putative target 
of Grem2-mediated inhibition [290]. Thus it appears that two of the most highly 
induced early aldosterone-regulated gene products (Grem2 and Atf3) act onto 
common targets via distinct pathways. 
 Besides hypothetical effects as the one suggested above for Atf3, the actual role 
in aldosterone-sensitive distal nephron of the two early aldosterone-induced CREB 
family members Atf3 and of Crem remains to be established. In this context, it is 
noteworthy that aldosterone synergizes with vasopressin and with other cAMP-
inducing hormones in stimulating Na+ and water reabsorption in these kidney 
tubular segments [291]. This synergy might implicate also transcriptional effects, 
besides posttranscriptional regulatory mechanisms at the level of ENaC and AQP2 
surface expression and function, since AVP has been shown to regulate many 
genes in cultured collecting duct cells [292]. 
Our list of early aldosterone-regulated mRNAs included also 13 mRNAs that are 
downregulated (Table 2). The known mRNA with the highest fractional decrease 
(0.3-fold in Affymetrix screen, 0.2-fold by real-time RT-PCR) encodes G0s2 a 
putative G0/G1 switch gene the downregulation of which might prevent 
proliferation and thus favor differentiation. The function of this gene product might 
be to stimulate cell proliferation and thus aldosterone would favour cellular 
differentiation by decreasing its expression [293]. 
Interestingly, there are also two transport proteins among the downregulated gene 
products, namely the polyspecific organic anion transporter Oat3 (Slc22a8) and 
the colonic H+,K+-ATPase. 
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The next downregulated gene product on the list is Oat3 (Slc22a8), a polyspecific 
organic anion transporter expressed in many tissues, including kidney proximal 
tubule and adrenal cortex. One of its functions that might be relevant in the context 
of aldosterone action is its capacity to transport steroids, for instance cortisol, 
across the plasma membrane [294]. It is also interesting that the colonic H+,K+-
ATPase, which participates in K+ absorption and H+ secretion from the tubular 
lumen, appeared among the downregulated gene products. This supports the 
notion that the stimulation of K+ secretion by aldosterone is not only a by-product 
of the increase in Na+ reabsorption but also a distinct action of aldosterone 
involving different gene products. Indeed, a decrease in apical H+,K+-ATPase 
expression (and function) is expected to lead to a decrease in K+ (re)absorption 
from the tubular lumen. 
 
2. Role of Deubiquitylation in Aldosterone Action 
 
The regulation of the gene products discussed in the previous section appears to 
favour a decrease in proliferation of aldosterone target cells and to foster their 
differentiation. Additionally our screen identified with Sgk1 and Usp2-45 two 
aldosterone-induced gene products interfering with protein ubiquitylation. As 
mentioned in the Introduction, Sgk1 was identified earlier as aldosterone-induced 
mRNA and protein and its effect on ENaC function has been shown to be 
mediated to a large extent by its inhibitory action on the ubiquitylating enzyme 
Nedd4-2. 
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Figure 24. Schematic representation of the convergent effect of Sgk1 and Usp2-45 that both 
decrease the amount of ubiquitylated ENaC and thus increase the amount of intact channel. The 
subcellular localization of these ubiquitylation/ deubiquitylation reactions has not yet been 
identified. 
 
We have now indeed shown that the newly identified aldosterone-induced Usp2-
45 directly deubiquitylates ENaC in the Hek273 cell expression system (Figure 
23.A). As expected if the ubiquitylation of ENaC would lead to ENaC degradation, 
the presence of Usp2-45 not only decreases the amount of ubiquitylated ENaC but 
also increases the total amount of ENaC. This biochemical evidence of ENaC 
deubiquitylation by Usp2-45 is supported by functional experiments made in 
Xenopus oocytes that show an increase in ENaC function specifically mediated by 
Usp2-45 and that depends on the integrity of its protease motif. Furthermore, we 
show both that the disruption of ENaC PY motifs and the disruption of ENaC lysine 
residues potentially targeted by Usp2-45 prevent the action of Usp2-45 on ENaC 
function. These results also strongly support the hypothesis that Usp2-45 acts on 
ubiquitin moieties ligated onto ENaC by the ubiquitin ligase Nedd4-2. 
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The fact that a deubiquitylating enzyme acting on ENaC is induced by aldosterone 
strengthens the notion that ubiquitylation plays a central role in the short-term 
regulation of ENaC. Although deubiquitylation of target proteins has been 
described since the early days of the ubiquitin system discovery [295], it has only 
recently gained considerable interest as a regulatory mechanism (for a review on 
deubiquitylation see [283]). The mouse as the human genome encodes 
approximately 100 putative deubiquitylating enzymes, the function of most of 
which is not known. 
Table 3. Present called Usp‘s in either the 
aldosterone or control condition in mouse 
CNT/CCD. 
Affymetrix© probe set IDs, gene name and gene 
symbol are listed 
 
 
The Affymetrix screen presented in this 
work revealed that approximately 26 of 
these Usp’s are expressed (Table 3.) in the 
aldosterone target cells of the mouse 
kidney tubule (present calls), but only 
Usp2-45 appeared in the list of regulated 
RNAs (Table 2.). Based on our results, the 
deubiquitylation of ENaC by Usp2-45 
appears to be quite specific for Usp2-45 
since none of the four other Usp’s that we 
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tested in expression systems activated and/or deubiquitylated this channel (Figure 
19.C, D and unpublished results). As yet, actually only few examples of plasma 
membrane protein deubiquitylation have been published. One such example is the 
deubiquitylation of yeast membrane permeases that leads to their targeting to the 
vacuole (equivalent to the mammalian lysosome) by the ubiquitin-specific protease 
Doa4 [296]. Another is the deubiquitylation and stabilization of the epidermal 
growth factor receptor by the endosomal ubiquitin isopeptidases AMSH and UBPY 
[297, 298]. 
The identification of ENaC as target of Usp2-45 represents the first report of a 
hormonally controlled channel-deubiquitylating mechanism. It is noteworthy to 
mention that this effect is not selective for kidney tubule, since Usp2-45 is also 
expressed and regulated in distal colon, yet another target epithelium of 
aldosterone (Fakitsas and Verrey, unpublished results). Previously published data 
on Usp2 suggests that its isoform Usp2-69 is regulated by androgens in liver and 
prostate where it deubiquitylates and stabilizes fatty acid synthase [286]. 
Furthermore, Usp2 was shown to be regulated in bone by parathyroid hormone 
[299], indicating that the Usp2 gene products mediate various important 
hormonally regulated functions. 
The fact that the stimulatory action of Usp2-45 on ENaC depends on prior ENaC 
ubiquitylation indicates however that Usp2-45 induction cannot explain the effect 
of aldosterone on Liddle-type mutant ENaC (see Introduction [300, 301]). Thus it is 
expected that still other aldosterone-induced gene products, possibly also 
identified in our screen, act via different pathways on ENaC expression and 
function. 
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In summary, our list of early aldosterone-regulated gene products contains two 
induced elements that interfere with the ubiquitylation of ENaC. Besides Sgk1 we 
identified Usp2-45 that we show to deubiquitylate ENaC in expression systems 
and thus represent a first example of a deubiquitylating enzyme acting on a 
channel. 
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2.1. Outlook 
 
The results presented in this PhD thesis have contributed to the understanding of 
the physiologically relevant early aldosterone-mediated effects on Na+ absorption 
in the distal nephron. Using a novel approach involving Affymetrix® GeneChips® 
we identified new early aldosterone targets. Previously only two gene products, K-
Ras2 and Sgk1, had been identified and experimentally shown to have an impact 
on ENaC function. In addition we now add Usp2-45 as a new player acting on the 
same axis of ENaC-mediated aldosterone effects. Moreover we characterized the 
role of Usp2-45 as the first hormonally regulated deubiquitylating enzyme known 
to be acting on a channel protein. 
This study has had and will continue to have an impact on future studies focusing 
on different and more tissue specific roles of Usp2-45 e.g. in heart or colon. These 
continuing studies range from solving the crystal structure (the main focus of 
Benjamin Oberfeld’s project) to the possible effects of Usp2-45 on the voltage-
dependent Na+ channel in heart, which is the focus of studies at the Lab of Hugh 
Abriel in Lausanne. 
The microarray studies provided a valuable initial list of candidate genes. For 
example, four interesting genes from this list, Hv1, Usp53, Atf3 or Grem2, which 
are all significantly differentially expressed in the aldosterone-treated group, can 
be further functionally characterized for example, through the use of inducible 
exogeneous expression in cell model systems. Another potential strategy is the 
tissue specific knock-out of the genes in order to investigate the resulting 
phenotype. These studies, which are now the focus of Gabriele Adam’s and Tina 
Dauwalder’s projects, might give deeper insights into aldosterone-dependent 
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proton transport as well as reveal the transcriptional switches involved in the 
aldosterone-ENaC cascade. 
A second goal of our work, which was to determine whether Usp2-45 has 
regulatory effects on target(s) in addition to kidney, was approached through a 
second set of microarray studies performed on heart and colon tissue dissected 
from mice previously used for the kidney microarray experiments (see Results 
section). This study indicated a role for transcriptional factors like NF-kappa, 
supporting the idea that in kidney and colon aldosterone mediates cellular 
differentiation rather than proliferation. 
In summary, the gene lists from these microarray studies have both shed light on 
the physiological mechanism of early aldosterone action and allowed us to pose 
new questions regarding the complex picture of aldosterone related Na+ 
absorption. 
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1. Introduction 
 
The systemic actions of aldosterone are well documented; however, in 
comparison, our understanding of the cellular and molecular mechanisms by 
which aldosterone orchestrates these actions is rudimentary. Aldosterone is 
thought to exert most of its physiological actions by modifying gene expression. It 
is now apparent that aldosterone represses more genes (~ 2/3) as it induces. 
Several aldosterone-sensitive genes, including Sgk1, Usp2-45 and small, 
monomeric Kirsten Ras GTP-binding protein (Ki-ras) have been identified. The cis-
acting elements and some molecular mechanisms bestowing corticosteroid 
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sensitivity onto these and many other genes have been described to some extent 
but the cell-specificity conferring mechanism of this action remain to a large extent 
to be unravelled. Induction of Ki-Ras and Sgk1 has been shown to be necessary 
and sufficient to elicit some portion of aldosterone action in epithelia. These two 
signaling factors are components of a converging regulatory network with 
phosphatidylinositol 3-kinase positioned between them that enables both 
stabilizing the epithelial Na+ channel (ENaC) in the open state as well as 
increasing the number of ENaC in the apical membrane. This aldosterone-
regulated signalling network contains many potential sites for feedback regulation 
and cross-talk from other cascades and potentially impinges directly also on 
cellular differentiation [78]. 
Besides acting on epithelial target-cells of kidney, colon, sweat glands etc., 
aldosterone acts also on non-epithelial sites like heart, brain and vasculature 
[302]. 
Moreover, numerous experimental and clinical studies indicate that aldosterone 
participates in cardiac alterations associated with hypertension, heart failure, 
diabetes and other pathological entities. It is important to mention that dietary salt 
is a key factor in aldosterone-mediated cardiovascular damage, since damage 
was more evident in animals on a high-salt diet than on a low salt diet. Some 
pathophysiological actions of this hyperaldosteronism in cooperation with salt 
excess involve development of extracellular matrix and fibrosis, inflammation, 
stimulation of reactive oxygen species production, endothelial dysfunction, cell 
growth and proliferation. Many studies have found that local extra-adrenal 
production of aldosterone in brain blood vessels and in the heart, contributes to 
the pathological actions of this mineralocorticoid [303]. 
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1.1. Mechanisms of Aldosterone Action 
 
Inhibitors of transcription and translation, as well as other experimental 
manoeuvres, have been employed to demonstrate that induction of gene 
expression is a necessary mechanism for the full action of aldosterone in epithelia 
(reviewed in Refs. [19, 304-306]). However, the possibility, that gene repression is 
also needed for aldosterone action, has been more difficult to demonstrate. This is 
in part due to the fact that genes negatively regulated by aldosterone have not 
been well described. Recently, a number of aldosterone-repressed transcripts 
have been identified [42, 292]. It is now apparent that aldosterone represses 
approximately as many genes as it induces. It follows that aldosterone-induced 
gene repression plays an important, but yet undefined role in the cellular 
response. 
 
In this study we compare aldosterone-sensitive regulatory gene products from 
three tissue types (kidney, colon and heart) that were affected by the short-term 
treatment of mice with aldosterone. 
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2. Materials and Methods 
 
2.1. RNA purification, Microarray Sample Preparation, Hybridization and 
Scanning 
 
The organs for this study were harvested from the same female C57BL/6JOlaHsd 
mice (Harlan), used in Fakitsas et al. [307]. The hearts were removed and the 
colon mucosas (up to 2 cm upstream of the rectum) were carefully scraped off 
using a sharp blade. Tissues were directly transferred into RLT lysis buffer 
(Qiagen RNeasy Mini Kit, Qiagen) for total RNA isolation. 
The quantity and quality of the isolated RNA was determined using a NanoDrop® 
UV-spectrophotometer ND 1000 (NanoDrop Technologies) and NanoChip® for a 
Bioanalyzer 2100 (Agilent Technologies). Only those samples with a 260 nm/280 
nm ratio between 1.8–2.1, a 28S/18S ribosomal RNA ratio within 1.5–2 and a RNA 
Integrity Number (RIN; Agilent Technologies) >7 (range 1-10 with 10 for best RNA 
quality) were further processed for target cRNA preparation. RNA amplification 
and labelling was performed according to a one-cycle cDNA synthesis protocol. 
Total RNA (<2 µg) was used for first and second strand cDNA synthesis with the 
GeneChip® One-Cycle Synthesis Kit (Affymetrix, heart) or the SuperScript cDNA 
Synthesis Kit (Invitrogen, colon) in the presence of an oligo-dT primer containing a 
T7 RNA polymerase promoter site. The resulting cDNA was then in vitro 
transcribed in the presence of biotin-labelled nucleotides (UTP’s) using the 
GeneChip® IVT Labeling Kit (Affymetrix Inc., P/N 900449), purified and quantified 
using the BioRobot Gene Exp – cRNA Target Prep (Qiagen AG). The labelled 
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cRNA were tested for quality using the Agilent 2100 Bioanalyzer® (NanoChip®, 
Agilent Technologies) and for quantity using the ND-1000 NanoDrop® UV-
spectrophotometer (NanoDrop Technologies). Only samples showing labelled 
cRNA average size distribution higher than 0.5 kb were accepted for hybridization. 
Target cRNA Hybridization and GeneChipGeneChip® Scanning were performed 
accordingly to manufacturers’ manual. 
 
2.2. Quality Control of Microarrays and Statistical Analysis 
 
Four, (in case of colon and heart) or six (in case of CCD/CNT) GeneChips® per 
condition were used for hybridization. Each hybridization was performed with 
target RNA from individual mice. Array images were examined visually for 
artefacts and B2 Oligo performance. Raw data processing was performed using 
the Affymetrix® Gene Chip Operating System Software (GCOS 1.4, Affymetrix) 
and the Genespring software 7.2 (Agilent). Summarization for the respective probe 
sets giving rise to the actual expression values was carried out using the GCRMA 
algorithm as described by Wu and Irizarry, 2004. 
Genes were filtered out from values in Genespring 7.3 when not showing a non-
logarithmic expression value of at least 50 in 3 out of 4 and 4 out of 6, 
respectively, of all replicate measurements of at least one condition. For each 
tissue, unequal variance t-tests were applied to detect genes that were 
significantly differentially expressed between aldosteron treated and control mice. 
A P-value of ≤ 0.05 was defined significant. Finally, the resulting significant genes 
were filtered for fold changes with a cut-off value of ≥ 1.8 between the conditions. 
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2.3. Real-Time RT-PCR 
Samples of 3 µl RNA (out of 60 µl) were used as templates for reverse 
transcription using TaqMan® Reverse Transcription Kit (Applied Biosystems) in the 
presence of 2.5 µM random hexamer primers (Applied Biosystems). Real-time 
PCR was performed using 3.5 µl of the cDNA as template using the TaqMan® 
Universal PCR master mix (Applied Biosystems). Primers and probes were 
designed using Primer Express 2.0 software (Applied Biosystems) to result in 
amplicons of 70-100 bp that span intron-exon boundaries. Each primer pair was 
first tested on mouse kidney cDNA and resulted in a single product of the 
expected size (data not shown). Probes (Table 1.) were labelled with reporter dye 
FAM at the 5’ end and the quencher dye TAMRA at the 3’ end (Microsynth). 
Reactions were run in 96-well optical reaction plates using a Prism 7700 cycler 
(Applied Biosystems). Thermal cycles were set at 95°C (10 min) and the 40 cycles 
at 95°C (15 sec) and 60°C (1 minute) with auto ramp time. To analyze the data, 
the threshold was set to 0.06 (value in the linear range of amplification curves). All 
reactions were run in triplicates and the abundance of the target mRNAs was 
calculated relative to a reference mRNA (mouse β-actin). Assuming an efficiency 
value of 2 (fold-increase in input mRNA required to decrease the cycle number by 
1), relative expression ratios were calculated as R = 2(Ct(β-actin) – Ct(test)), 
where Ct is the cycle number at the threshold and test stands for the tested 
mRNAs. Based on this analysis, some samples (<1/3) were excluded from 
microarray target RNA synthesis because of a relatively low enrichment in α- and 
βENaC mRNA or, for aldosterone-treated mice, a Sgk1 upregulation <2-fold. Real-
time RT-PCR was performed similarly for controlling the regulation of 8 mRNAs 
considered as highly regulated by microarray. 
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3. Results 
 
The RNA samples prepared from single mice were tested in terms of quantity, 
integrity, enrichment; contamination and response to aldosterone (Figure 15.C and 
D). These measurements revealed that in micro-isolated CNT/CCD segments 
ENaC mRNA was enriched 15 - 40-fold over total kidney, whereas thick-ascending 
limb-specific triple cotransporter Nkcc2 mRNA was not increased. Sgk1 mRNA 
was enriched 3 - 4-fold over the total kidney preparation and specifically further 
increased 5 - 6-fold by aldosterone. The manipulation of mice slightly increased 
plasma corticosterone levels (Figure 14.A and B) but not Sgk1 expression (Figure 
15.C and D). Relative to kidney, mouse colon showed an inverted profile of ENaC 
subunit mRNA expression. 
 
 
 
 
 
 
 
 
 
 
Figure 25. Test for aldosterone stimulation of RNA prepared from colon. Mice were injected with 
aldosterone and RNA prepared from colon obtained after 1 h. The abundance of α-, βENaC and 
Sgk1 mRNAs was measured by real-time RT-PCR. Given are means relative to β-actin ± SEM, n = 
4 mice. ***P<0.001 by 1 way-ANOVA. 
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As expected, colon had a higher gene expression of the ENaC α-subunit (5 
times higher) than of the β-subunit. Furthermore Sgk1 was around 6.5 fold induced 
while no induction of  ENaC subunits was observed in the aldosterone- versus the 
non-treated mice (Figure 25). 
 
 
 
 
 
 
 
 
 
 
Figure 26. Test for aldosterone stimulation of RNA prepared from heart. Mice were injected with 
aldosterone and RNA prepared from heart after 1 h. The abundance of α-, βENaC and Sgk1 
mRNAs was measured by real-time RT-PCR. Given are means relative to β-actin ± SEM, n = 4 
mice. ***P<0.001 by 1 way-ANOVA. 
 
Heart showed very low levels of α- to ‘no’ levels of β-ENaC expression and no 
significant regulation of α- or β-ENaC after aldosterone stimulation. A small but 
significant induction of Sgk1 (around 2 fold) was detected (Figure 26). It must be 
conceded that this effect might be not only MR but also GR mediated (2-fold 
induced corticosterone after 1 h of aldosterone injection; Figure 14.A). 
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More than two thirds of the CNT/CCD-prepared RNA samples fulfilled the 
selection criteria for quantity, integrity, enrichment, Sgk1 induction and lack of 
contamination and could be used as template for cDNA amplification and labelled 
target RNA synthesis. Target cRNAs made from 6 control and from 6 aldosterone-
injected mice were separately hybridized to mouse full genome GeneChip® 
microarrays (MOE 430 v2, Affymetrix). For colon and heart 4 samples per 
condition were prepared for target cRNA sample preparation and microarray 
hybridization. Raw array data were processed using the GCRMA algorithms. The 
data were filtered by setting a cut-off for raw values of RAW ≥ 50 in 4 out of 6 
arrays per condition for the case of CCD/CNT. In the case of colon and heart the 
raw values were filtered by RAW ≥ 50 in 3 out of 4 arrays per condition. Finally a t-
test was applied with a cut-off P-value of P ≤ 0.05 and using a fold-change limit of 
1.8. Genes which passed these criteria were later used to generate an overlap list 
(Table 4.). 
 
Table 4. Commonly differentially expressed genes in CNT/CCD; colon and heart 
 
 
The output list (Table 4.) shows that only 4 genes (Sgk1, Usp2, period homolog1 
and DNA segment Chr 17) were commonly differentially expressed with a fold 
change of ≥1.8 in at least 2 tissues:.Using these criteria, in kidney and colon the 
only gene products that show differential gene expression are Sgk1 and Usp2. 
In order to investigate these data, we focused in detail on the organs colon and 
 
CCD/CNT Colon Heart
serum/glucocorticoid regulated kinase 4,5 5,0 n.a. NM_011361 Sgk1
ubiquitin specific peptidase 2 2,3 2,0 n.a. AI553394 Usp2
period homolog 1 (Drosophila) n.a. 2,2 2,4 AF022992 Per1
DNA segment, Chr 17, human D6S56E 5 2,4 n.a. 0,5 NM_033075 D17H6S56E-5
gene name fold change Gene Bank Symbol
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heart. In collaboration with PD C. Cohen we then further investigated 2 gene lists 
(kidney and colon) focusing on the promoter regions upstream of the origin of 
transcription. The analysis tool `Bibliosphere` was used to investigate microarray 
data. Bibliosphere extract knowledge about the gene-gene interactions from 
available literature databases and promoter analysis of a list of genes. In our case 
this list of genes is constituted by the lists of significantly expressed genes. The 
Bibliosphere tool generates figures that show regulatory networks. 
In kidney, out of the top 20 induced genes eight are transcription factors (TF). Out 
of the 465 significantly differentially regulated genes (fold change ≥ 1.0, P ≤ 0.05) 
identified in the kidney, 28 are TFs. This quantitatively important regulation of TF’s 
suggests the activation of cellular processes that might mediate the cellular 
changes/differentiation induced by aldosterone. The output figure of the 
bibliosphere analysis of the kidney data set acuminate to Nfkb1 (activating form), 
which is repressed in kidney (CNT/CCD, 1.13 fold) (Figure 27.) 
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Figure 27. Bibliosphere analysis of kidney (CNT/CCD) data showing the network of transcription factors involved by the stimulation of aldosterone. 
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Moreover we could find Nfkb2 (inhibitory form) to be induced (1.4 fold). In 
comparison colon shows no Nfkb regulation, although the number of genes in this 
group is higher. 
Further information is the induction of Cdkn1a in kidney, which appears to be one 
of the acuminating points in the bibliosphere analysis. 
A different set of gene products were found to be regulated by aldosterone in 
colon. For instance, colon shows regulation of 5 heat-shock proteins (HSPA 1b 
and 8 up; 4, 4I and 9a down), which was not seen in kidney. 
 
Addendum  103 
 
Figure 28. Bibliosphere analysis of colon data showing the network of transcription factors involved 
by the stimulation of aldosterone. 
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Figure 28.(continued) Bibliosphere analysis of colon data showing the network of transcription 
factors involved by the stimulation of aldosterone. 
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Figure 28.(continued) Bibliosphere analysis of colon data showing the network of transcription 
factors involved by the stimulation of aldosterone. 
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Another observation for colon is the repression of Myc (Figure 28.). Additionally; it 
is striking that unlike in kidney no TF could be found among the top 20 regulated 
genes. In total 84 TFs out of a total of 1488 significantly differentially regulated 
genes (fold change ≥ 1.0, P ≤ 0.05) were found. Other regulated gene products 
which might play important roles in aldosterone action in the colon are 
prostaglandine PGES2, MAPK1 and SP1 (Figure 28.). 
 
We then examined the heart microarray data sets in comparison to those of the 
epithelial tissues from kidney and colon. We also examined a small subset of 
genes representative for different function by real-time RT PCR. In particular, we 
found by real-time PCR a modest but significant increase in Sgk1 mRNA of around 
1.7 fold (Figure 26.). This confirmed that the heart can be considered as an 
aldosterone-sensitive tissue in which, similarly to colon and kidney, Sgk1 is 
activated by short-term aldosterone treatment. In addition to Sgk1, glucocorticoid-
induced leucine zipper (GILZ, TSC22 domain family 3), which has been previously 
described to be induced by aldosterone in other cell types, was also increased as 
well in heart (around 2-fold). 
In addition to SGK1 and GILZ, which are involved in cellular signaling pathways, 
our microarray identified Rgs2 (Table 5.) another early aldosterone-induced 
regulatory gene product in mice heart [308]. Rgs proteins play a key role in the 
regulation of G protein-coupled receptor signaling. G protein-coupled are activated 
by many extracellular signals that regulate cardiomyocyte growth and 
differentiation. The heart expresses several Rgs proteins but their individual roles 
in regulating cardiovascular function are still not clear [309]. 
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Table 5. Differentially expressed genes in mice heart 
 
Genes involved in inflammatory processes were identified as significantly 
regulated by short term aldosterone (Table 5.). Among them the nuclear factor of 
kappa light chain gene enhancer in B-cells inhibitor, alpha (Nfkbia) showed a 
significant increase of around 1.5 fold. Nfkbia belongs to the PAR1-dependent 
transcripts, which are known to counter-balance the inflammatory response to 
PAR activation by limiting prolonged activation of p38 MAPK and increased 
cytokine production [310]. Another gene product involved during acute 
inflammation is the CCAAT/enhancer-binding protein delta (C/EBP delta) (Table 
5.), which belongs to the family of leucine zipper transcription factors. In mice 
heart C/EBP delta shows after aldosterone treatment an induction of around 2.6 
fold. Additionally, ADAMTS1, a metalloprotease that is highly expressed in the 
heart and is likely important for the structure or regulation of extracellular matrix, 
shows a moderate but significant increase of around 1.4 fold. 
 
 
 
 
 
gene products
Genbank Gene Symbol RATIO
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 1 D67076 Adamts1 1.35
CCAAT/enhancer binding protein (C/EBP), delta BB831146 Cebpd 2.65
nuclear factor of kappa light chain gene enhancer in B-cells inhibitor, alpha NM_010907 Nfkbia 1.417
regulator of G-protein signaling 2 AF215668 Rgs2 1.557
serum/glucocorticoid regulated kinase NM_011361 Sgk 1.515
TSC22 domain family 3 NM_010286 Tsc22d3 2.137
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4. Conclusions 
 
The main objective of the present study was the identification and comparison of 
early aldosterone-regulated gene products in mouse heart, colon and kidney using 
different bioinformatic tools to unravel the potential different functions of 
aldosterone in these tissues. Among the gene products that were found to be 
regulated by aldosterone were members of regulatory networks that are related to 
proliferation, differentiation and stress reactions. Those regulatory networks are to 
some extent common to the different aldosterone target tissues. Regarding kidney, 
one example is the induction of Cdkn1a, which appears to be one of the 
acuminating points in the bibliosphere analysis, revealing that aldosterone action 
directly targets regulatory networks controlling cell cycle progression, terminal 
differentiation, and apoptosis [311]. 
Another important gene product among the aldosterone-regulated transcription 
factors in kidney is NFkB. NF-kappa B comprises a family of transcription factors 
thought to have a central role in the expression of genes involved in cell 
mobilization, cell proliferation and cell differentiation, and, hence, in inflammation, 
repair and fibrosis processes. In particular, NF-kappa B activation has been shown 
to participate in a number of inflammatory diseases of the kidney that progress to 
end-stage renal failure [312]. In this context, another interesting regulated 
transcription factor is myc (Ndrg-1) that is regulated in particular in colon. Ndrg-1 
has been identified as a protein involved in the differentiation of epithelial cells 
[313]. In addition, Ndrg-1 expression can be regulated by androgens and is 
involved in the pathology of the disease [314]. 
Aldosterone, in addition to its well-established effects on epithelial target cells, has 
Addendum  109 
been suggested to exert direct effects on the cardiovascular system. The main 
known effects of aldosterone in classical target tissues are mediated via changes 
in transcription. On the other hand, only a few genes that are clearly regulated via 
the MR have been described in cardiac or vascular tissues in cell culture. Among 
these is Sgk1, which as in renal epithelia [29, 110, 315] is induced by aldosterone 
in mouse heart tissue. Aside from the four common aldosterone-regulated genes 
shared by heart and kidney epithelial cells, it seems likely that the majority of the 
early aldosterone-regulated genes in cardiomyocytes are different from those 
regulated in epithelia. Importantly, our experiments identified in heart a number of 
early regulated genes whose role in cardiovascular function has been established 
but their aldosterone-regulation was previously unknown, as well as other genes 
that are likely to have a function in cardiac pathology. 
In this study we were interested in identifying regulated gene products that have 
some obvious or putative connection to the regulation of extracellular matrix or 
cardiac remodeling, for example ADAMTS1, which could play a role in 
aldosterone’s fibrotic effects. ADAMTS1, a metalloprotease and disintegrin, was 
originally cloned as an inflammation-associated gene [316]. Later it was shown 
that ADAMTS1 is induced by myocardial infarction in cardiomyocytes and 
endothelium within the infarct zone [317]. Furthermore, ADAMTS1 can disrupt 
extracellular matrix remodeling [318], and its overexpression accelerates 
atherosclerosis and neointima formation [319]. 
Another group of genes rapidly up-regulated by aldosterone in heart includes 
genes that have been implicated in inflammation and acute phase reaction. 
Among those we found Nfkbia and C/EBP delta, both gene products known to play 
a role in acute inflammation or stress [320]. Further, GILZ, which we found to be 
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up-regulated by aldosterone belongs to this category of acute-phase proteins 
[321]. 
Rgs2, a gene rapidly induced by aldosterone in heart, is involved in signal 
transduction and regulation of vascular tone. Rgs proteins are multifunctional 
signaling regulators and exert GTPase-activating protein activities. Many signals 
that regulate cardiomyocyte growth, differentiation, and function are mediated via 
heterotrimeric G proteins, which are controlled by Rgs proteins. Rgs proteins are 
necessary for normal cardiovascular function and are involved in hypertrophy and 
development of heart failure [322]. Changes in cardiac Rgs2 levels and in G(q/11) 
signaling produce cardiovascular phenotypes. Furthermore, haploinsufficiency 
and/or elimination of the Rgs2 gene lead to hypertension in mice [323]. Rgs2 is 
activated via the nitric oxide-cGMP pathway, which might be part of the 
mechanism by which it regulates blood pressure [324]. A recent study showed that 
transgenic mice with activated Gq signaling develop heart failure, but the 
contractile dysfunction and structural abnormalities improved significantly after 
termination of the Gq signal [325], suggesting that Rgs2 could be beneficial in 
heart failure. Such an effect is difficult to reconcile with a predominantly constrictor 
action of aldosterone and with the current dogma that aldosterone is detrimental in 
heart failure. On the other hand, induction of Rgs2, and probably other proteins 
that are cardioprotective, might be part of a compensatory feedback mechanism 
initiated by aldosterone. 
Aldosterone also regulates the expression of several genes that may contribute to 
the development of cardiovascular damage (fibrosis, vasculitis) under pathological 
conditions. Blocking aldosterone regulation of these genes by MR antagonists 
such as epleronone or spironolactone might contribute to the beneficial effects 
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observed in patients with chronic heart failure. However, it seems that activation of 
the MR by aldosterone also induces genes, such as Rgs2, that are likely to exert 
cardioprotective effects and thus might be beneficial in preventing heart failure. 
In summary, the analysis of gene regulation by a short-term aldosterone treatment 
in kidney, colon and heart reveals surprisingly little common regulated gene 
products between kidney and colon, despite their common function in Na+ 
transport. Importantly however, Sgk1 and Usp2-45 were regulated similarly in 
these two epithelial tissues, stressing their central role for mediating aldosterone 
action. In all three tissues aldosterone targets, in particular by regulating 
transcription factors, regulatory networks involved in cell proliferation, 
differentiation and stress reaction. In that respect, it is interesting to note that there 
are apparently more common actions in heart and kidney than in colon and kidney. 
Taken together, these results and their analysis indicate that the short-term 
transcriptional action of aldosterone is relatively specific for each tissue type. 
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